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Examination of the Acute Hepatic and Renal Toxicity from the Concurrent Oral
Exposure to Chloroform and Trichloroethylene.
By Michelle Ziegler Lilly
(Under the direction of Dr. Jane Ellen Simmons and Dr. Louise M. Ball)
Increased hepatic and renal toxicity occurs following concurrent exposure to
carbon tetrachloride (CCI4) and trichloroethylene (TCE) relative to that seen
from each chemical alone. Consequently, the interaction of TCE and
chloroform (CHCI3), a close structural analogue of CCI4, was examined. Adult
male F-344 rats were gavaged with 0, 0.5 or 1.0 ml CHCl3/kg, 0 or 1.0 ml
TCE/kg or their factorial combinations in corn oil. Urine was collected at 0, 6,
12, 24, 36 and 48 hrs, and hepatotoxicity was assessed at 24 and 48 hrs. To
examine the influence of gavage vehicle, additional rats were gavaged with 0,
0.5 or 1.0 ml CHCl3/kg, 0 or 1.0 ml TCE/kg or their factorial combinations in an
aqueous vehicle (10% Emulphor 620). Urine was collected at 0, 6, 12, 24, 36
and 48 hrs, and hepatotoxicity was assessed at 24 and 48 hrs. CHCI3 alone
caused hepatic and renal toxicity. At 48 hours post dosing, serum AST and
LDH were observed to increase 88-146 fold and 45-48 fold, respectively, when
CHCI3 was administered in corn oil. Increases in AST and LDH were
significant when CHCI3 was administered in the aqueous solution; however,
elevations were no more than 3-fold for either enzyme. Vehicle differences
were also observed in increases of ALT and bile acids. Both were significantly
elevated when administered in oil compared to the aqueous vehicle. Peak
hepatotoxicity was observed to be 48 hours when CHCI3 was administered in
oil whereas in the aqueous vehicle, 24 is greater or equal to 48 hours, based
on elevations in ALT and bile acids.
CHCI3 appeared to be more nephrotoxic when administered in the oil vehicle
compared to the aqueous. Histopathological lesions (both renal tubule
degeneration and renal tubule necrosis) were more severe in the groups
receiving CHCI3 in oil compared to the aqueous vehicle. In contrast to CHC13,
TCE alone was not overtly toxic to either organ. Concurrent exposure to both
CHCI3 and TCE produced significantly less toxicity relative to CHCI3 alone.
This was observed in serum enzymes at 24 and 48 hours and in urinary
enzymes at 36 and 48 hours. Additionally, histological lesions were
consistently less severe when CHCI3 was administered in the presence of TCE
compared to CHCI3 alone. In conclusion, hepatic and renal toxicity were
observed following CHCI3 exposure and no effects were observed from TCE
alone. CHC13 was significantly more acutely hepatotoxic when administered in
an oil than in an aqueous vehicle. Relative to CHCI3 alone, serum and urinary
indicators were significantly decreased following concurrent administration of
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I.   Introduction
Human contact with chemicals, environmentally or occupationaily,
seldom occurs as a single exposure to an individual substance. It is well known
that we are exposed to many hundreds of compounds, both synthetic and
natural, on a daily basis. As a result, knowledge of the toxicity from single
chemical exposures, based on animal toxicity assessments, may not accurately
predict the effect of multiple exposures to chemicals in conjunction with other
confounding environmental factors. The pursuit of understanding and
characterizing such interactions is an important one if we are to ultimately,
accurately predict the human health consequences of exposure to multiple
chemicals in the environment.
There is a pressing need to evaluate the toxicity of complex chemical
mixtures and since drinking water is a potential media for multiple exposure to
potentially large populations, assessing the public health risk associated with
drinking water and the maintenance of drinking water quality are high priorities
for environmental regulatory and public health agencies. Contaminants
associated with the disinfectant process such as trihalomethanes (THMs) as
well as other volatile organic compound (VOC) contaminants commonly found
in water have been the focus of much interactive toxicity investigations.
Concurrent exposure to a binary mixture of carbon tetrachloride (CCI4)
and trichloroethylene (TCE) is known to result in a potentiation of toxicity
(Simmons et al., 1992; Pessayre et al., 1982; Borzelleca et al., 1990; Steup et
al., 1991). Also, simultaneous exposure to CCI4 and chloroform (CHCI3) has
been shown to exert a more than additive effect (Borzelleca et al., 1990; Steup
et al., 1991; Harris et al., 1982). Chlordecone (Hewitt et al., 1980) and ethanol
(Strubelt, 1980) have both been found to potentiate the toxicity of CCI4;
additionally, both compounds are known to potentiate the toxicity of   CHCI3
(HGwitt et a!., 1980).
Both CHCI3 and TCE are commonly found at hazardous waste sites
(Grisham, 1986) and as waste sites are potential sources of groundwater
contamination, the simultaneous occurrence of the two compounds in drinking
water is probable. Additionally, since CHCI3 is formed by chlorination of
surface waters for disinfection, this increases the importance of studying this
particular VOC and its potential interactive capabilities with other drinking water
contaminants.
TCE is known to potentiate CCI4, and since CCI4 and CHCI3 are
structurally similar compounds, it was the objective of this study to examine the
possible interaction of CHCI3 and TCE, to characterize the dose dependence of
any observed interaction and to examine the effect over time. This would
provide us with information on the behavior of two structurally similar binary
mixtures.
Digestible oils are the classical vehicle for volatile, lipophilic compounds
which are poorly soluble in water (Kim et al.,1990a). As a result, most health
risk assessments are based on data derived from orally gavaged animal studies
that utilized oil as the vehicle of administration. The oil vehicles were previously
thought to be inert but there is increasing evidence that it may be a confounding
factor. Alterations in physiological effects, target organ dose, absorption,
distribution, metabolism, elimination and toxicity may result from the vehicle
used to administer the chemical (Kim et al., 1990a; Condie et al., 1986). In
addition, corn oil may alter the nutritional status of the animal which might alter
the toxicity of the compound of interest (Condie et al., 1986). It has recently
been shown that corn oil affects the activity of P450IIE by increasing the
concentrations of the isozyme (Yoo et al., 1990). HE is known to be the isozyme
responsible for the metabolism of CHCI3 (Brady et al., 1989) as well as other
VOCs.
Drinking water is one of the exposure routes of interest for these
chemicals and evidence exists that the degree of toxicity observed from
administration in an oil vehicle is different from that observed following
administration in an aqueous vehicle in aliphatic halogenated hydrocarbon
studies (Chieco et al., 1981; Kim et al., 1990a; Condie et al., 1986).
Differences in rate and extent of uptake in pharmacokinetic studies have been
observed for chlorinated hydrocarbons when administered in oil solutions as
compared to aqueous solutions (Withey et al., 1983); thus, another aspect of
this study was to compare the toxicity produced by CHCI3 and TCE alone and
in combination when given in both oil and aqueous vehicles.
il.    Literature Review
A.   Introduction
The National Research Council (NRC)(1984) proposed a scheme to
prioritize and identify chemicals for toxicity testing and hazard ranking.
Important factors included in the prioritizing procedure include:
1. a chemical being present at the disposal site
2. its potential for release and migration through the environment
3. its potential for resulting in adverse human health effects
4. its recognition by the scientific community and or general public as being a
chemical causing concern.
In addition, the Mitre Corporation (1983) compiled a list of chemicals or
groups of chemicals that were reported as being present in the environment in
the vicinity of the then 546 National Priority List (NPL) sites which had been
designated by the Environmental Protection Agency (U.S. EPA) as mandated
under Comprehensive Environmental Response, Compensation and Liability
Act (CERCLA) and are identified by U.S. EPA as being disposal sites causing
documented environmental concern.
According to the Mitre study, trichloroethylene (TCE) was found at
129/546 NPL sites and chloroform (CHCI3) was found at 68/546. When ranked
by frequency of occurrence, TCE was first followed by toluene, benzene, lead
with chloroform ranked 5th. The Conservation Foundation (1984) also reported
that EPA had evaluated approximately 900 sites for possible inclusion on the
NPL for cleanup and CHCI3 and TCE were among the ten most commonly
reported substances at these sites.
Considering the NRC criteria and the information regarding the
prevalence of chloroform and trichloroethylene in the environment, these are
two of the many contaminants which merit further toxicological evaluation.
Knowledge of the toxicity based on exposure via drinking water is of interest
since it is a potential route for human exposure. In addition, the interaction of
the two compounds is of importance since in many instances simultaneous
exposure is plausible.
B.   Chloroform:   Occurrence in the Environment
CHCI3 occurs naturally; however, the majority in the environment is due
to anthropogenic activities. In 1989, 587.6 million lbs of CHCI3 was produced
in the U.S. (SOC 1955-1990). CHCI3 is primarily used to make fluorocarbon-
22, a component of the cooling fluid for air-conditioners (ATSDR, 1989a). In
addition it is used in the manufacturing of pesticides, dyes, fire extinguishers,
spot removers, solvents for penicillin, vitamins, alkaloids, lacquers, floor
polishes, waxes and adhesives (ATSDR, 1989a).
Releases into the environment occur from the pulp and paper
manufacturing process, pharmaceutical and chemical manufacturing plants and
from the chlorination of waste and drinking water (ATSDR, 1989a). CHCI3 was
widely used in drug, cosmetic and food products until it was banned for those
purposes by EPA in 1976 (Grisham, 1986).
Routes of Exposure
Human exposure to CHCI3 can occur via ingestion, inhalation or dermal
contact; however, the exposure pathway of primary concern for the general
population is ingestion. CHCI3 enters drinking water from the chlorination
disinfection process as well as contamination of surface and groundwater from
chemical spills and waste disposal sites. The major exposure is via ingestion of
contaminated ground water (Grisham, 1986); however, occupationally,
inhalation may be a major route. Inhalation and dermal, in addition to oral
exposures, in the domestic environment are now of increasing concern for
health-based risk assessments (Jo et al., 1990).
CHCi3 has been found in concentrations ranging from 0.7 to 540 ug/L
with a mean concentration in all waters of 14 ug/L (U.S.EPA 1990). In a study
monitoring CHCI3 in surface water supplies of 80 cities, values ranged from
less than 0.3 to 311 ug/L (Grisham, 1986).   A U.S. EPA survey of finished
drinking water found a 70.3% occurrence in samples taken from ground water
supplies (Grisham, 1986). Higher concentrations of CHCI3 are found in
finished drinking water that has high levels of humic/fulvic acids and algal
growth, an alkaline pH, and relatively warm temperatures (U.S.EPA 1981).
Alternate disinfection processes are available to lower the CHCI3 levels;
however, they can be costly and unavailable to smaller water treatment
facilities.
CHCI3 is one of several trihalomethanes (THMs) which are currently
regulated collectively by EPA. In efforts to protect public health from drinking
water exposure, EPA has promulgated a drinking water maximum contaminant
level (MCL) for total THMs of 100 ppb (ug/L) as technically and economically
feasible for municipal water supplies serving 10,000 people or more (ATSDR,
1989a).
Toxicological  Profile
For both inhalation and ingestion routes of exposure, the systemic target
organs for toxicity are the liver, kidneys and central nervous system (CNS)
(ATSDR, 1989a). The liver and kidney are the most sensitive target organs with
CNS toxicity observed only at very high exposures. Toxic hepatitis and liver
enlargement were found in workers exposed by inhalation to CHCI3 at levels of
2 to 205 ppm over a period of 1 to 4 years (Bomski et al., 1967). A fatal oral
dose of CHCI3 may be as little as 10 ml (211 mg/kg) for a 70 kg human
according to Schroeder (1965). A wide range of oral LD50 values (lethal dose
that kills 50% of the treated animals) have been reported; the ATSDR reports
that the LD50 values for rats are 444 to 2000 mg CHCI3/kg and 118 to 1400 mg
CHCI3/kg for mice depending on age, sex and strain.
In a chronic study, rats were gavaged with dosages greater or equal to
90 mg CHCI3/kg/day for 78 weeks and then observed for the following 33
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weeks. Mortality was found to be dose related, due perhaps to liver toxicity (NCI
1976). In mice, gavaged with CHCI3 for 78 weeks and observed for 14-15
weeks, a dosage of 477 mg/kg/day resulted in decreased survival whereas
dosages less than 238 mg CHCI3/kg/day did not (NCI 1976).
Levels of acute oral exposures found to produce any liver and kidney
effects in humans are not known; however, a patient who ingested 2.6 to 11.6 g
CHCI3/day in cough medicine for approximately 10 years developed hepatitis
and necrosis (Wallace, 1950). It has been noted that confounding factors make
these results difficult to interpret. The NOAEL (no observable adverse effect
level) for humans is currently set at Img CHCI3/kg/day for liver and kidney
toxicity (ATSDR, 1989a). The acute oral NOAEL and LOAEL (lowest
observable adverse effect level) for target organ toxicity in mice are set at 18
and 30 mg CHCI3/kg, respectively (ATSDR, 1989a). Rats have been found to
more resistant to CHCi3 toxicity with the acute NOAEL and LOAEL being 30
and 150 mg CHCI3/kg respectively (ATSDR, 1989a).
An epidemiological study uncovered a possible relationship between
human exposure to chlorinated drinking water and cancer of the bladder, large
intestine and rectum (U.S.EPA, 1985). CHCI3 is one of several volatile organic
contaminants (VOCs) considered to have carcinogenic potential, but has yet to
be identified as the main cause of cancer associated with chlorinated drinking
water (ATSDR, 1989a).
Metabolism and Hepatotoxicity
When orally ingested, CHCI3 is absorbed rapidly through the intestinal mucosa,
a dose-dependent first-pass effect occurs with pulmonary elimination of the
unchanged compound (ATSDR, 1989a). Mink et al., (1986) administered single
oral doses of 100 mg 1'^C-CHCIS/kg in corn oil (16uCi/kg) to rats and mice. In
rats the total recovery was 78% after 8 hours, 65% of which was expired as
unm©taboll2ed CHCI3, 6.5% was expired as C02, 2.6 % was excreted in urine
and 3.6% was recovered in organs. A greater extent of metabolism was found
in mice with 26% expired as unchanged CHCI3 and 49.6% as C02 with total
recovery of 94%.
Large interspecies and sex differences in metabolism, tissue distribution
and covalent binding to tissue macromolecules make dose and species
extrapolations difficult (ATSDR, 1989a). Dogs appeared to be the most
sensitive species to CHCI3 induced hepatotoxicity. The liver is generally the
most sensitive target organ but in some male mice strains such as the ICR, the
kidneys were more susceptible.
In order to exert toxicity, CHCI3 must first be metabolized (Pohl, 1979).
This occurs primarily in the liver and kidneys and has been found to be a
saturable process. The exhalation of CO2 is a major route of elimination with
the concentration of CO2 in the exhaled breath being dose dependent. The
liver converts CHCI3 to C02 approximately 5 times more rapidly than the kidney
with the adipose, blood and muscle tissue exerting little influence on CHCI3
metabolism (Paul and Rubenstein, 1963; Pohl, 1979). The metabolic activity is
localized in the microsomal fraction of liver homogenates and depends upon
the presence of pyridine nucleotides (Pohl, 1979). The pretreatment of animals
with inducing agents of liver microsomal cytochrome P-450 such as ethanol,
DDT and phenobarbital markedly increased the hepatotoxic response to CHCI3
(Pohl, 1979). In contrast, when animals are pretreated with inhibitors of liver
cytochrome P-450 such as SKF 525-A or piperonyl butoxide, a decrease in
hepatotoxicity is found .
CHCIS is known to deplete liver glutathione (GSH) in rats by a process
which appears to involve a CHCI3 metabolite based on the observation that an
increased amount of GSH depletion was found in  rats pretreated with
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phenobarbltal (Pohl, 1979). GSH, a scavenger of electrophillic compounds
which can potentially bind to tissues may react with the CHCI3 metabolites and
protect against any resulting hepatotoxicity. This role is supported by the
observation that hepatotoxicity is potentiated when liver GSH is depleted by
pretreatment with diethyl maleate (Pohl, 1979). GSH depletion in the liver is a
rapid process. Within 1 hour after the interperitoneal (ip) administration of 0.2
ml CHCI3/kg to phenobarbital-treated rats, it was observed that approximately
59% of the GSH was depleted (llett et al., 1973).
CHCI3 metabolites have been reported to bond covalently in vivo to
macromolecules such as protein, lipids or nucleic acids in the target organs
where it causes tissue damage (llett et al., 1973). A correlation between the
extent of covalent binding of CHCI3 metabolites to tissue macromolecules and
tissue damage and toxicity has been reported (Pohl, 1979). Pretreatment with
inhibitors or inducers of P-450 decrease or increase, respectively, the amount of
liver damage and the amount of covalent binding (Pohl, 1979). Pohl reports
that the covalent binding of CHCI3 metabolites displays a striking preference for
the accumulation in the centrilobular hepatocyctes and in the proximal
convoluted tubular cells in the kidney.
Histological studies have shown that CHCI3 causes marked alterations
of cellular organelles. The rough endoplasmic reticulum shows fragmentation
and loss of ribosomes and a depression in protein synthesis is observed
(Smuckler, 1976). This functional loss is believed to be in part responsible for
the accumulation of fat seen in the liver based on the knowledge that excretion
of lipid from the liver requires a carrier protein.
As early as 1915 it was suggested that phosgene (C0CI2) was a
metabolite of GHCI3 (Pohl, 1979). The potential mechanism for the biological
formation of C0CI2 from CHCI3 is outlined in Figure I.  The trichloromethanol
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(CI3-C-0H) would not be expected to be stable and would spontaneously
dechlorinate to C0CI2 since the only trihalomethanol derivative found in the
literature is trifluoromethanol (F3C0H) a compound which spontaneously
dehydrofluorinated at -200 C {Pohl, 1979). The C0CI2 is extremely
eiectrophillic since it is a di-acyl chloride and consequently will react with any
nucleophile, nucleophilic thiol or hydroxyl and amino groups in protein and
lipids and therefore be responsible for the covalent binding and the depletion of
hepatic GSH.
Cysteine is known to react rapidly with C0CI2 to form 2-oxothiazolidine-
4-carboxylic acid (see Figure 2). Thus, using cysteine as a trapping agent,
since C0CI2 is reactive and volatile, it was concluded that phosgene was in fact
a metabolite of CHCI3 (Pohl et al., 1977).
CDCI3 is known to be metabolized more slowly than CHCI3 suggesting
that the cleavage of the C-H bond of the CHCI3 was the rate determining step in
this enzymatic process (Pohl, 1979). This observation supported the proposed
oxidative dechlorination mechanism for CHCI3. Other potential toxic
metabolites of CHCI3 include the trichloromethyl radical and the dichloromethyl
carbene (Pohl, 1979).
Nephrotoxicity
In addition to eliciting hepatotoxicity, CHCI3 is known to be nephrotoxic.
The lesion is localized primarily in the proximal tubule and characterized by a
marked increase in kidney weight and swelling of the tubular epithelium, which
is associated with marked necrosis and tubular casts (Lock, 1989). Species
differences have been observed in the renal metabolism of CHCI3 by the rat in
contrast to the mouse or rabbit. In a study by Smith et al. (1985) rat renal
cortical tissue was found to metabolize CHCI3 to C02 and a reactive
intermediate capable of binding to macromolecules.  The extent of metabolism
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in the rat tissue was substantially less than that observed previously with mice
and rabbit renal tissue.   In addition, an atmosphere of CO:oxygen (80:20) did
not alter CHCI3 toxicity in rat renal cortical slices whereas CO did reduce
CHCI3 toxicity in mouse renal cortical slices (Smith and Hook,1983).
Hepatic vs Renal Toxicity and Metabolism
It has been suggested that the renal metabolism of CHCI3 may not
involve cytochrome P-450 as much as the hepatic metabolism due to the
inability of CO to reduce CHCI3 toxicity in rat renal cortical slices (Pohl, 1979).
This suggestion was supported by the observation that the severity of CHCI3
nephrotoxicity in vitro did not differ between Fischer-344 and Sprague-Dawley
rats although the concentration of renal cytochrome P-450 has been shown to
be two-fold greater in the Fischer-344 rat strain (Smith et al., 1985).
Consequently, there appears to be a difference in the metabolism of CHCI3 in
the kidney and liver microsomes. This is supported by the finding that in vivo
CHCI3 did not deplete GSH in the kidney of the rat as it did in the liver (Docks
and Krishna, 1976). Thus, the activation of CHCI3 by oxidative dechlorination
may not occur in the rat kidney as it does in the liver since no kidney glutathione
is depleted and it does not appear to be catalyzed by P-450 (Docks and
Krishna, 1976).
Various ketonic solvents are capable of potentiating CHCI3-induced
renal and hepatic toxicity in rats (Hewitt et al., 1983). In Sprague-Dawley rats,
the potentiation of hepatic CHCI3 toxicity by 2-hexanone (methyl-n-butyl
ketone) is associated with increased concentration of hepatic cytochrome P-
450, increased bioactivation of CHCI3 to phosgene, and increased depletion of
hepatic GSH (Branchflower and Pohl, 1981).
The findings that 2-hexanone treatment did not increase the total level of
renal microsomal cytochrome P450 or lead to a depletion of total renal GSH
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after the administration of CHCI3 suggested that the metabolism of CHCI3 to
C0CI2 may not occur in the kidney (Branchflower and Pohl, 1981). These data
suggested that the mechanism of CHCI3-induced nephrotoxicity in rats may
differ from that of hepatotoxicity (Smith et al., 1985). CHCI3-induced murine
nephrotoxicity was only observed in males (Smith and Hook, 1983). The renal
metabolism of CHCI3 to phosgene (trapped as 2-oxothiazolidine-4-carboxylic
acid) requires the presence of 02 and NADPH and can be inhibited by CO
supporting a role for cytochrome P-450 in this species (Lock, 1989).
Administration of CHCI3 to male mice produced a depletion of renal GSH,
indicating that phosgene is also formed in vivo as a metabolite in mouse kidney
(Lock, 1989). Incubation of CHCI3 under an atmosphere of CO diminished the
toxic effects showing further evidence of renal metabolism suggesting oxidative
metabolism of CHCI3 by cytochrome P-450. The levels of renal cytochrome P^
450 and associated monooxygenases were 3 to 5 times higher in the male vs
female mice and pretreatment with diethyl maleate a GSH depletor, increased
male but not female susceptability, suggesting sex differences in kidney
metabolizing enzymes (Smith and Hook, 1983).
Reductive Metabolism
A large number of studies have suggested that the CHCI3 activation
process depends on the microsomal drug metabolizing system and is
influenced by the presence of oxygen (Pohl, 1979). In a study by Tomasi et al.,
(1985) about 30% of the metabolism of CHCI3 still occurs under anaerobic
conditions, suggesting the presence of a reductive metabolic pathway. It is
known that halomethanes compete with oxygen for electrons supplied at the
cytochrome P-450 locus, thus metabolic reduction is favored at a low 02
tension (Tomasi et al., 1985). Tomasi found that several THMs (CHCI3 and
chlorodibromomethane (CHCIBr2) undergo reductive metabolism in isolated
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hepatocytes incubated under nitrogen and give rise to free radical
intermediates (Tomasi et al., 1985). Additionally, Testai and Vitozzi, (1986)
recently demonstrated that the induction of rats with phenobarbital dramatically
stimulates the hypoxic reductive bioactivation of CHCI3. The investigators
concluded that the hypoxic bioactivation may have a role in CHCI3 toxicity.
Testai and Vitozzi, (1992) have extensively studied both reductive and oxidative
metabolism of CHCI3. The investigators have proposed 3 processes that
produce chemically reactive species from chloroform. Two of these are
oxidative, but differ in their affinity for CHCI3 and O2. The products formed by
these processes are not different and both bind to lipids and proteins and are
efficiently scavenged by GSH. The difference is that one has been observed to
be inhibited by lower O2 tension than the other. The third process is inhibited
by oxygen and gives rise to a protein-lipid binding ratio similar to that
attributable to trichloromethyl radicals. This may represent the reductive
formation of radicals in agreement with TomasI (1985). The investigators
propose that in the centrilobular region of the liver, the oxidative process is
limited because of the low O2 tension and allows the reductive pathway to
proceed at the maximum level.
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C.    Trichloroethylene:    Occurrence in the Environment
Approximately 200 million lbs of TCE are used annually in the United
States (ATSDR, 1989b). Roughly 80% is used as a solvent for the vapor
degreasing of fabricated metal parts and the remaining 20% for chemical
intermediates, miscellaneous use and exports (ATSDR, 1989b). Most of the
TCE is released into the atmosphere by evaporative losses from degreasing
uses and leaching to groundwater from waste disposal landfills (Sabel and
Clark,1984).
According to the Mitre study, trichloroethylene (TCE) was found at
129/546 NPL sites. When ranked by frequency of occurrence, TCE was first
followed by toluene, benzene, lead with chloroform ranked 5th. The U.S. EPA
Groundwater Supply survey of 945 water supplies nationwide using
groundwater sources found TCE in 91 of the 945; the median level of the
positive samples was ~1ppb with a single maximum level of 130 ppb (Westrick
et al.,1984). Various federal and state surveys indicate that between 9 and 34%
of the water supply sources in the U.S. may be contaminated with TCE (ATSDR,
1989b); thus, a main source of exposure occurs via ingestion of drinking water.
EPA has established a drinking water standard of 5 ppb which applies to
community water systems and those which serve the same 25 or more persons
for at least 6 months (ATSDR, 1989b). Occupational exposure is also of major
concern and OSHA regulates exposure at an average concentration of 50 ppm
in the air for an 8 hour day over a 40 hour week (ATSDR, 1989b).
Pharmacolcinetics
TCE is an uncharged, nonpolar and highly lipophilic compound that is
readily absorbed across the gastrointestinal mucosal barrier (ATSDR, 1989b).
Absorption following oral exposure in both humans and animals is rapid and
extensive.   In a study by Prout et al., (1985), male Osborne-Mendel and Alderiy
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Park Wistar-derived rats and Swiss-Webster and B6C3F1 mice were exposed
via a single intragastric administration to 10, 500, 1000, 2,000 mg/kg C^OTCE
in corn oil, (dosing volume was 1.0 ml for rats and 0.5 ml for mice). Metabolism
of TCE in the mouse was linear over the range of dosages whereas in the rat it
became constant and independent of dosage at 1000 mg/kg and above. At
2000 mg/kg TCE, 78 % of the dose was eliminated unchanged in the rat, but
only 14 % in the mice. Mice appear to have a greater capacity to metabolize
TCE, explaining their greater susceptability to TCE toxicity and carcinogenicity
(ATSDR, 1989b). No significant strain differences were observed throughout
the study other than the B6C3F1 mice having a higher tolerance to doses over
1000 mg/kg TCE.
The absorption characteristics of TCE are different depending on
whether the compound is administered to fasted or nonfasted animals. D'Souza
et al., (1985) found that in fasted male Sprague-Dawley rats (300-350g), TCE
administered in 50% aqueous suspension (PEG 400) was rapidly and
completely absorbed with peak blood concentrations 6-10 minutes after dosing.
In nonfasted animals the peak blood TCE concentration occurred at the same
time but the peak levels were 2-3 times lower than those observed in fasted
animals. Vehicle effects on absorption and peak blood concentration have
also been observed with TCE (Withey et al.,1983).
Toxicological Profile and Hepatotoxicity
Animal studies indicate that the liver and kidney are the principal target
organs of oral exposure to TCE (ATSDR, 1989b). In an acute study by Tucker et
al., (1982) to determine the LD50 in male and female CD-1 mice, TCE was
administered in 10% Emulphor by gavage in a volume of 0.01 ml/g body weight.
No deaths occurred at dosages up to 750 mg/kg for females and 1250 mg/kg for
males. There was 100% mortality at 5500 mg/kg for females and 6000 mg/kg in
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males. Consequently, the oral LD50s were determined to be 2443 mg/kg for
female mice and 2402 mg/kg for male mice (ATSDR, 1989b). Tucker et
al.,1982, also conducted a subchronic study in which male weanling CD-I mice
were exposed to 24 or 240 mg TCE/kg/day in 10% Emulphor (0.01 ml/g body wt)
for 14 days by oral gavage. Increased liver weight was the only treatment-
related effect. Based on this study, 240 mg/kg represents the NOAEL for
hepatic and renal effects for acute oral exposure (ATSDR, 1989b). The
dosages of 5,620 mg/kg/day and 3,160 mg/kg/day represent the LOAEL and
NOAEL respectively for intermediate oral lethality in rats (ATSDR, 1989b).
In intermediate duration oral studies using male B6C3F1 mice, 2,400 mg
TCE/kg by oral gavage in 10 ml/kg corn oil for 3 days caused centrilobular
hepatocellular swelling with focal hepatocellular necrosis. Dosages of 500-
1200 mg TCE/kg by oral gavage in 10 ml/kg corn oil caused increased relative
liver weights in male B6C3F1 mice when administered 5 days/week for 3 weeks
(Stott et al., 1982). The highest NOAEL for liver effects in mice is 1200 mg
TCE/kg for intermediate duration oral exposure and the only dosage associated
with necrosis was 2400 mg TCE/kg which Is designated as the LOAEL (ATSDR,
1989b).
TCE is extensively metabolized (40-75% of the retained dose in humans)
to trichloroethanol (TCE-OH), trichloroethanol-glucuronide and trichloroacetic
acid (TCA) with minor metabolites including chloral hydrate monochloroacetic
acid and n(hydroxyacetyl) aminoethanol.(ATSDR, 1989b) Three urinary
metabolites account for -90 % of the total TCE, TCA (15%), TCE-OH (12%) and
conjugated TCE-OH(62%). (DeKantetal., 1984).
Rouisse and Chakrabarti (1986) pretreated adult male Sprague-Dawley
rats with phenobarbital then administered 0 to 2 ml TCE/kg in corn oil ip 16
hours after fasting. A maximum of only 29% depletion of hepatic GSH occurred
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within 2 hours when 1 ml TCE/kg was administered to phenobarbital-pretreated
rats with concentrations returning to control values within 6 hours and
increasing significantly 24 hours after the dose. These results suggest that the
conjugation of hepatic glutathione with the electrophilic intermediate of TCE
does not appear to be a major detoxification pathway for TCE therefore
unimportant in TCE hepatotoxicity. In addition, administration of TCE resulted in
a dose-dependent decrease of liver microsomal cytochrome P-450 content,
reaching an apparent plateau at about 1.0 ml TCE/kg. At this saturation dosage
the concentration of P-450 was decreased to 51% of controls. Rouisse and
Chakrabarti (1986) suggested that the reactive intermediate produced by
metabolic activation through the MFO system may form ligand complexes with
microsomal cytochrome P-450 with simultaneous loss of mixed function oxidase
activity. This study indicated a.good correlation between decreased MFO
activity or cytochrome P-450 content and the extent of liver injury. It was also
shown that there exists an apparent saturable metabolism of TCE including its
activation deactivation pathways which correspond to an apparent threshold (or
minimal) toxic dose (eg ~1ml TCE/kg for its hepatotoxicity).
Nephrotoxicity
Chakrabarti and Tuchweber (1988) demonstrated that TCE exerts its
acute nephrotoxic potential only at a very high dose level and produces
nephrotoxic insult at the proximal tubule and possible glomerular regions of the
rat kidney when exposed by inhalation or ip routes.
Treatment of male Fischer-344 rats (150-180g) with up to 11 mmol
TCE/kg (0.99 ml TCE/kg) in corn oil per kg body weight (ip) did not influence
any of the measured biochemical parameters of nephrotoxicity. Also
significantly elevated levels of urinary N-acetyl-b-D-glucosaminidase (NAG) as
well as serum urea nitrogen were observed at 24 hours only at the highest dose
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iQvel, 22mmol TCE/kg (1.97 ml TCE/kg) (Chakrabarti and Tuchweber, 1988).
Consequently, TCE is known to exert hepatotoxicity well before any nephrotoxic
damage is evident.
D.   Oral Gavage Vehicles for Lipophilic Compounds
Health risk assessments of drinking water contaminants have typically
been based on the results of toxicity studies in which the chemical is
administered to the animal orally in an oil vehicle. There is increasing concern
that the administration of an oil bolus will not only produce physiological effects
but alter pharmacokinetic parameters such as the absorption or target organ
dose and in so doing possibly alter the effects or introduce confounding factors
which could significantly affect the accuracy and relevance of oral toxicity
studies (Kim et al.,1990a).
Digestible oils have classically been used as vehicles or diluents for the
volatile lipophilic VOCs because of their poor solubility in oil at concentrations
used for toxicity tests (Kim et al.,1990a). An alternative to corn oil is the use of
emulsifying agents to solubiize hydrophobic compounds in aqueous vehicles
for oral gavage or drinking water exposure. Emulphor, for example, is a
nontoxic liquid (Oral LD50=40g/kg in rats) prepared by polyoxyethylation of
castor oil (GAF corp). It serves as a nonionic surfactant to produce an oil in
water emulsion.
Following is a discussion of several studies demonstrating that the
toxicity or pharmacokinetics of certain VOCs can be significantly affected by the
vehicle in which the chemical is administered.
Withey et al. (1983) evaluated the relative uptake of equivalent doses in
vegetable oil and aqueous dosing vehicles of CHCI3, TCE, dichloroethane and
methylene chloride in male Wistar rats (~400g) in a dosing volume of 3-5ml.
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Area under the curve (AUC) blood-concentration time curves and maximum
concentration (Cmax) following intragastric dosing were assessed. Absorption
was rapid in both vehicles but, the rate and extent of absorption varied greatly
with vehicle. The peak concentration of CHCI3 in blood after administration
was 39.3 ug/ml when administered in water and 5.9 ug/ml when administered
in corn oil. This could be due to the faster partitioning of the CHCI3 with
mucosal lipids from the aqueous vehicle relative to the oil vehicle since CHCI3
is a lipophilic compound. The time to peak blood concentration occurred
slightly more rapidly with the aqueous vehicle (5.6 min ) than the oil (6.0 min).
An even greater difference was observed in the case of TCE where the
AUC ratio of aqueous to oil was 218 (CHCI3 was 8.70). Witheys study
revealed that the most similar uptake between oil and aqueous, based on AUC
ratios, occurred with methylene chloride which had the highest aqueous
solubility whereas TCE was the most different and had the lowest aqueous
solubility. Clearly the oil-water partition coefficient had an important bearing on
the uptake from an oil solution into the Gl tract showing that the vehicle can
produce substantial effects by altering the systemic bioavailability of a lipophilic
substance. Also the uptake of the VOCs was more pulsed from the oil than the
aqueous possibly due to the dose breaking up into immiscible globules.
Chieco et al., (1981) studied the effects of different vehicles (corn oil and
aqueous emulsion) when 200 mg 1,1 DCE/kg (dichloroethylene) was given to
fed and fasted adult male Sprague-Dawley rats. In the fasted rats massive injury
[(>100 fold increase of alanine aminotransferase (ALT) and aspartate
aminotransferase (AST)] was observed in corn-oil treated animals with
moderate injury (~15 fold increases of ALT and AST) in rats receiving the
aqueous solution. In contrast the fed groups showed only slight liver injury in
groups receiving both vehicles.
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Exhalation concentrations were also measured every 15 min for 5 hours.
In both fed and fasted animals, the most rapid decline occurred when the
compound was administered in aqueous vehicle. The exhalation of 1,1 DCE
has an initial rapid phase followed by a slower period occurring one hour
following exposure. Exhalation was slightly delayed in the fasted groups in the
early phase whereas in the later phase, the vehicle appeared to have a marked
Influence on 1,1 DCE exhalation. The half life of the 1,1 DCE after the 2nd hour
was 103 min for the corn oil vs 42 min for the aqueous. There was little
influence of the vehicle on the total percent of the dose exhaled; however, the
half life (ti/2) values reflect a marked influence of the administrative vehicle.
Chieco found that the hepatotoxicity of 1,1 DCE in fasted animals was
diminished when the compound was given in the aqueous solution, and based
on the exhalation of the parent compound can be correlated with the more rapid,
clearance of 1,1 DCE from the body. Thus Chieco demonstrated that both
fasting and vehicles can greatly affect the absorption and toxicity.
Condie et al. (1986) evaluated the effects of gavage vehicle on the
severity of the subchronic hepatotoxicity of CCI4 in male and female CD-I mice
gavaged with 0, 1.2, 12 or 120 mg CCI4/kg in either corn oil or 1% Tween-60
for 90 days (5 days/week). The study revealed greater hepatotoxicity in the
mice that received CCI4 administered in corn oil. In this study the data indicate
the NOAEL based on subchronic data in corn oil was 1.2 mg CCI4/kg whereas
the NOAEL for aqueous was 12 mg CCI4/kg. In a subchronic study by Bull et al.
(1986), 270 mg/kg/day CHCI3 was administered in corn oil or 2% Emulphor for
90 days in Iml/IOOg dosing volume by stomach tube to male and female
B6C3F1 mice. CHCI3 administered in the corn oil vehicle resulted in greater
hepatotoxicity than when the chemical was given in an aqueous vehicle.
in a subacute study by Merrick et al. (1989) concentrations up to 2400
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mg/kg/day of TCE were administered to male and female B6C3F1 mice in either
corn oil or a 20% aqueous solution of emulphor (1ml/100g body weight) for 4
weeks. Within the first week, all male mice exposed to 2400 mg/kg/day died
and 8/12 of the female mice died when exposed to 1800 mg/kg/day
administered in Emulphor. In contrast, only a few male mice died when
exposed to TCE in oil. TCE in Emulphor proved to be more lethal but less
hepatotoxic because those that survived for 4 weeks appeared to have less
hepatocellular necrosis compared to the animals receiving TCE in oil.
Additionally, serum enzyme levels (AST, ALT and LDH) were significantly
elevated in the corn oil group compared to the aqueous group. Merrick
concludes that the high oil water partition coefficient of TCE for corn oil delays
the rate and extent of Gl uptake reducing the peak blood levels over
administration in aqueous vehicle, affecting both bioavailability and toxicity.
Kim et al. {1990a) assessed the acute hepatotoxicity of 0-1000 mg
CCI4/kg in male Sprague-Dawley rats {200-230g). CCI4 was administered by
oral gavage in corn oil or 0.25% Emulphor (5ml/kg) as well as pure chemical (3-
4 ul) and water (6-8 ml dosing volume). Animals were fasted 18 hours prior to
chemical administration. Dose response increases in serum enzyme levels
were observed in each vehicle; however, serum enzymes were consistently
lower in groups given CCI4 in oil. Kim noted that the use of aqueous Emulphor
emulsions appears more appropriate in acute toxicity studies of VOC drinking
water contaminants since similar responses of toxicity were observed in the
groups receiving CCI4 in Emulphor, when compared to the pure chemical or the
administration in water. In an additional study by Kim et al. (1990b), the
effects of dosing vehicle on the pharmacokinetics of orally administered CCI4 in
rats were examined. Fasted 200-230g male Sprague-Dawley rats received 25
mg CCI4/kg in corn oil, Emulphor, water and as pure chemical, in the same
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dosing volumes as the previous study. Differences in the acute hepatotoxicity
had been observed in the companion study by Kim et al {1990a) and the
objective was to relate the pharmacokinetics of the vehicle effects,
bioavailability and absorption to the effects seen in the acute study. Corn oil
markedly delayed the absorption of CCI4 from the Gl tract and produced
secondary peaks in the blood concentration vs time profile. There was a high
degree of correlation of both Cmax and AUC measured from 0 to 120 min with
hepatotoxicity. Kim found that CCI4 was less acutely hepatotoxic in corn oil
due to delay and prolongation of CCI4 absorption resulting in a marked
decrease in the concentration of the chemical in the arterial blood and liver.
Corn oil likely acts as a reservoir in the Gl tract slowing the systemic
absorption and consequently altering the overall pharmacokinetics, metabolism
and resulting toxicity in comparison to chemical administration in an aqueous
solution. An understanding of the importance of studying the toxic effects of a
contaminant in the media in which exposure is most likely to occur is becoming
a more relevant issue as the influences of vehicles are being observed.
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E.   Chemical Interactions
Toxicological assessment of chemical interactions is a difficult task. It is
important not only to assess the biological effects of exposure to chemical
mixtures but also the pharmacokinetic influences as well as determining the
mechanisms of interaction. This information could aid in the interpretation of the
chemical interactions which would allow for tissue dose and species
extrapolations and ultimately more accurate assessments of the health risk of
multiple chemical exposure.
It has been noted that CHCI3 toxicity is influenced by substances that
alter microsomal enzyme activity or hepatic GSH levels (ATSDR, 1989a).
Disulfuram, an inhibitor of microsomal drug metabolizing enzymes has been
observed to decrease the hepatotoxicity of chloroform (Jorgensen et al., 1988).
Andersen et al. (1987) evaluated the in vivo interaction of TCE and 1,1.
dichloroethylene (DCE) in vivo in male Fischer-344 rats. Both compounds are
metabolized by single saturable oxidative pathways with high affinity substrate
binding. Rats were exposed for six hours to 0, 100, 200, 300 and 400 ppm 1,1
DCE. A dramatic increase in AST levels was observed above the 100 ppm
concentration. When coexposed to both 1,1 DCE and TCE, TCE was held
constant at 500 ppm and 1,1 DCE concentrations were 300, 713 and 1718 ppm.
In the presence of TCE, the concentration response curves were shifted to the
right indicating a inhibition of 1,1 DCE metabolism. Consequently, higher
concentrations of 1,1 DCE in the presence of TCE were required to produce the
same elevation in AST compared to 1,1 DCE alone. An excellent
correspondence between predicted and observed behavior was noted when
the inhibition was assumed to be purely competitive.
Interactive hepatotoxicity of CHCI3 and CCI4 has been examined in male
Long-Evans rats (210-300g) by Harris et al. (1982). Chemicals were given ip as
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30% solutions in corn oil and rats were killed 24 hours later. When
administered alone 0.1 ml CCI4/kg lowered hepatic P450 concentrations and
0.2 ml CHCI3/kg had no effect. Marked histological changes were seen in
animals receiving both chemicals while only modest changes were seen in
animals receiving either chemical alone. Both compounds, singly and in
combination, failed to alter hepatic GSH concentrations. Harris concluded that
by several criteria of hepatotoxicity including serum ALT, triglycerides, calcium
concentration and histopathological changes, that subthreshold doses of
CHCI3 and CCI4 are hepatotoxic when given together.
Borzellecca et al. (1990) examined the interactions of two pairs of VOCS
using male Sprague-Dawley rats (200-250g). CCI4 (0-400 mg/kg) and CHCI3
(0-700 mg/kg) as well as CCI4 (0-400 mg/kg) and TCE (0-400 mg/kg) or the
individual chemicals were administered by oral gavage in 5% Emulphor.
Borzellecca found that the chemicals in combination displayed a synergistic
hepatic response for sorbitol dehydrogenase (SDH), ALT and AST, with the
peak plasma enzyme activity occurring at approximately 36 hours. In this study,
animals were fasted for 16-24 hours presurgery, then cannulated via the
carotid artery to allow for serial blood sampling. A total of 8 samples were
obtained (650ul each). Blood withdrawal and fasting may have stressed the
animals causing additional elevations in enzyme levels.
Steup et al. (1991) examined the interactions of CCI4 and CHCI3 as well
as CCI4 and TCE using drinking water for the route of exposure for TCE and
CHCI3 and following with an ip administration of CCI4. Male Fischer-344 rats
(175-250g) were pretreated for 3 days by administration of TCE or CHCI3 in
their drinking water followed by a challenge dose of Immol CCI4/kg In corn oil
via ip injection. TCE and CHCI3 alone produced no significant increase in
serum ALT activity.   When rats were pretreated with TCE and CHCI3, significant
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increases in the plasma ALT were observed in response to the CCI4 challenge.
Steup also conducted strain comparisons and investigated the most
appropriate plasma enzyme marker for hepatotoxicity. His results suggest that
the Fischer-344 rat is more sensitive to VOCs and VOC interactions than
Sprague-Dawley rats. The indicator most accurately representing
hepatotoxicity and tissue injury was ALT, which provided the clearest evidence
of the interactive toxicity consistent with the histological evidence.
Hewitt et al. (1983) demonstrated that the exposure of male Sprague-
Dawley rats (150-300g) to a variety of ketones can potentiate the hepatotoxicity
of a subsequent exposure to a haioalkane such as CHCI3. Animals were given
15 mmole/kg po of ketones (acetone, 2-butanone, 2-pentanone, 2-hexanone or
2-hepatatone) in corn oil (10 ml/kg) then challenged 18 hours later with 0.5 or
0.75 ml CHCI3/kg ip in corn oil (4ml/kg); liver injury was examined 24 hours
later. The relationship between carbon skeleton length of ketonic solvents and
potentiation of CHCI3 induced hepatotoxicity was examined. None of the
ketones from acetone to heptanone produced appreciable liver injury as neither
did CHCI3 alone. A marked degree of liver injury was produced by CHCI3 in
ketone pretreated rats. The severity of ketone potentiated CHCI3-induced liver
damage correlated with the ketone carbon chain length. The authors suggest
that while carbon chain length is a factor in determining the potentiating
capacity of a ketone, other factors are likely to be involved such as metabolite
biotransformation. Additionally, a positive correlation between liver weight and
ketone chain length was observed. It has been shown that several of the
ketonic solvents are capable of inducing hepatic mixed function oxidase activity
(Branchflower and Pohl, 1981) which might produce hypertrophy of the
endoplasmic reticulum and increase relative liver weight. Branchflower and
Pohl (1981) proposed that methyl n-butyl ketone potentiated chloroform
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hepatotoxicity by increasing P450 levels thereby enhancing chloroform
metabolism to phosgene and decreasing GSH levels.
Ethanol pretreatment is known to enhance the toxicity of hepatotoxic
agents (Strubelt, 1980). Substances that are potentiated by ethanol are
metabolized in the liver to toxic metabolites and include CCI4, CHCI3 and TCE
(Strubelt, 1980). This supports the hypothesis that an induction or activation of
the hepatic microsomal drug metabolizing system is responsible for ethanol-
induced potentiation of hepatotoxicity. Acute or chronic ethanol administration
is known to enhance the MFO activity, to enhance the in vitro and in vivo
covalent binding of ""^CCW to liver microsomal protein and to accelerate the in
vitro biotransformation of 14CCI4 to 14002 (Strubelt, 1980).
Pessayre et al. (1982) reported that ip administration of 64 ul CCI4/kg or
1 ml TCE/kg (in 0.5 ml liquid paraffin), did not significantly increase serum ALT
levels and did not significantly decrease hepatic cytochrome P-450
concentrations measured 24 hours later in male Sprague-Dawley rats (180-
220g). However, when CCI4 and TCE were administered simultaneously, ALT
activity increased markedly and a 55% decrease in the hepatic cytochrome P-
450 concentrations was observed. The mechanism of TCE potentiation of CCI4
has been under investigation. Pessayre found an association between lipid
peroxidation and hepatotoxicity which was proposed as the mechanism by
which TCE potentiates CCI4. In contrast, a study by Keflas and Stacy (1989)
showed that lipid peroxidation was not responsible for the TCE-induced
potentiation.
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F.   Methods   of Toxicological Evaluation:
Indicators of Hepatic Damage
Toxicological damage to organs can manifest itself in both functional and
morphological changes. The morphological or pathological processes involved
in the injury will largely determine the functional or biochemical alterations as a
result of injury (Plaa and Hewitt,1982). The four categories of tests that are
useful specifically for evaluation of hepatic injury include histological analysis,
serum enzymes, hepatic excretory function and alterations in chemical
constituents (Plaa and Hewitt, 1982).
The hepatic lesions induced by cytotoxic injury occur primarily in the
hepatocyte (Tyson et al., 1985). The injury may be characterized by steatosis,
the accumulation of lipids or necrosis, the appearance of degenerative
processes leading to the death of the cell, a small group of cells (focal necrosis)
or zonal damage or damage to virtually all cells in the lobule (massive necrosis)
(Plaa and Hewitt, 1982). Cholestatic responses also may occur involving
changes in the bile flow resulting in alterations of bile salts and bilirubin
concentrations (Plaa and Hewitt, 1982). Hepatomegaly, enlargement of the
liver, may be due to increased numbers of cells (hyperplasia) or an increase in
cell volume (hypertrophy) (Tyson et a!., 1985) Many, but not all, compounds
cause hepatomegaly and there is not always a correlation of hepatomegaly
and hepatotoxicity; thus, liver enlargement is viewed by some as an adaptive,
functional response rather than atoxic response (Mitoma, 1985).
In order to classify hepatic lesions, two schemes of the parenchymal
mass have been used to relate the hepatocytes with the vascular supply and
biliary system (Plaa and Hewitt, 1982). Based on the classical scheme, the
hexagonal lobule, hepatic lesions have been classified as centrilobular,
midzonal or periportal according to location relative to the terminal hepatic
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venule and the portal triad (Plaa and Hewitt, 1982). The acinar model has
corresponding regions of functional specificity and metabolic activity designated
as zones that are not incompatible with the classical description.
Serum enzyme levels have become the standard measure of hepatic
injury (Zimmerman, 1982). They are useful for early detection of liver damage
and for serial sampling over time. The significance of biochemical
abnormalities as indices of hepatic injury should be judged by the supporting
evidence of histological damage since there are limitations to their uses. Levels
may increase as a result of leakage from cells due to systemic effects other than
hepatic necrosis and in addition some forms of hepatic injury do not produce
elevations in serum enzyme levels (Zimmerman, 1982).
Zimmerman proposed the following classification for serum enzymes in
the detection of hepatic injury:
1. Those reflecting cholestatic alterations such as 5' Nucleotidase (5'NUC) and
Alkaline phosphatase (ALK PH).
2. Those reflecting cytotoxic injury subdivided as follows into those:
a) that are nonspecific and can reflect extrahepatic damage, such as
aspartate aminotransferase (AST) and lactate dehydrogenase (LDH).
b) that are mainly in liver, such as alanine aminotransferase (ALT).
c) that are exclusively in liver, such as sorbitol dehydrogenase (SDH).
The investigator states that the enzymes 5'Nuc, AST, LDH and ALT are the most
useful for the detection of hepatic toxicity.  They are sensitive to hepatic injury
and reach high concentrations in serum in response to parenchymal injury.
The transaminases are the most widely employed and generally
accepted serum measure of hepatic injury despite equal or greater
hepatospecificity of several other enzymes released to blood as a result of
hepatic injury. They are easily measured and have high degree of sensitivity to
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acute hepatic injury which accounts for the general dependence on the
transaminases as a means of detecting toxic liver injury. AST, a cytosolic
enzyme is found in several tissues besides liver, including muscle, myocardial
and kidney whereas ALT occurs mainly or almost exclusively in the liver
(Zimmerman, 1982). In virtually all mammalian species, AST is a sensitive
measure of acute hepatic necrosis when accompanied by the elevation of other
liver specific enzymes (Zimmerman, 1982). Plaa and Hewitt (1982) note that
ALT shows a very good correlation between serum levels and severity of
histological lesion since agents that produce severe necrotic lesions also
produce pronounced ALT elevation. Thus, ALT allows detection of the
presence of liver injury in addition to an estimation of the severity of the lesion
by the degree of ALT elevation.
SDH, like AST, is a cytoplasmic enzyme and is relatively specific for
hepatocellular damage (Plaa and Hewitt, 1982). In several studies, elevation of
SDH has been detected before other enzymes, thus it appears to be one of the
most sensitive enzymatic indexes when damage is minimal; however, it
appears to be less sensitive than histopathological evaluation (Plaa and Hewitt,
1982).
LDH is widely distributed in mammalian tissue with the myocardium,
kidney, liver, and muscle being especially rich. It is ubiquitous and it can be
released from erythrocytes with hemolysis; thus, it is highly variable in response
to a variety of conditions (Tyson et al., 1985). Total serum enzyme activity of
LDH may not be as useful as Isozyme analysis because changes in the
isozymes may go undetected. More specificity can be achieved but it does
require specific equipment and a more complex analysis (Mitoma, 1985). LDH
isoenzymes have been used in the evaluation of organ damage and are
specific to liver and kidney tissue thus providing the benefit of differentiation of
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organ damage (Plaa and Hewitt, 1982).  LDH5 is found in rats with liver Injury
and LDH1 and 2 are found in rats with renal damage (Plaa and Hewitt, 1982).
Gopinath et al. (1980) reported on the usefulness of bile acid clearance
and serum bile acid concentrations in rats with acute liver injury for detection of
biliary tract proliferation or obstruction. 5' NUC is another useful indicator of
obstructive liver injury as it is localized in the membranes of the hepatocyte and
bile ductular cells (Plaa and Hewitt, 1982). Alkaline phosphatase is found in the
kidney cortex, intestinal mucosa, bone, placenta and the liver which contains
relatively little in a variety of species including rats (Dooley, 1982).
Chemicals that are hepatotoxic can alter the activity of the hepatic mixed
function oxidase system, thereby changing the rate at which xenobiotics are
metabolized (Plaa and Hewitt, 1982). P450 plays a central role In drug
oxidation and thus serves as the binding site for several chemicals that are
oxidized in the liver to reactive metabolites (Plaa and Hewitt, 1982) including
CHCI3 (Brady et al., 1989) and TCE (Moslen, et al., 1990). The terminal
oxidase of the mixed function oxidase system, cytochrome P-450, is particularly
susceptible to damage and depletion and is an increasingly popular index of
damage to the endoplasmic reticulum (Plaa and Hewitt, 1982).
Finally, the measurement of urea, cholesterol, plasma protein and blood
glucose have been found to be insensitive and nonspecific in the monitoring of
hepatic injury (Zimmerman, 1982).
Indicators of Renal Damage
Histological examination of the kidney has been considered a useful
method for detecting chemically induced renal damage and is important in
determining the site of damage (Ohata et al., 1987). Renal pathological lesions
caused by chemical or biological agents primarily result in nephrosis
encompassing a range of changes from cell swelling to overt necrosis and
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desquamation of tubule cells (Tyson et al., 1985). Seventy-five percent of the
water the kidney filters is reabsorbed in the proximal convoluted tubule of the
nephron and consequently is found to be particularly vulnerable (Price, 1982).
The resulting concentration of the remaining fluid, coupled with the high blood
flow thru the kidney (25% cardiac output) makes it particularly vulnerable to
toxic attack (Price, 1982).
Two of the more commonly used serum indicators for renal injury in
animal toxicity studies are BUN and creatinine. Increases in BUN
concentrations can result from any damage to the nephron whether the lesion
occurs in the glomeruli or tubules or whether it affects renal blood supply and
thus indirectly the glomerular filtration rate (Tyson et al., 1985) BUN provides
no insight into site or nature of the lesion and is generally considered to be a
relatively insensitive marker for renal injury (Tyson et al., 1985). Berndt (1976)
noted that measurements of BUN are commonly used to assess glomerular
function. BUN increases as filtration slows or ceases. Serum creatinine is
derived from creatinine in skeletal muscle and is excreted by the kidneys mainly
by glomerular filtration Serum creatinine values do not increase significantly in
renal disease until kidney function is considerably impaired such as severe
toxic nephrosis (Tyson et al., 1985). Plasma creatinine levels parallel those of
BUN and are frequently used as a marker for glomerular filtration for acute renal
failure due to xenobiotic-induced damage as well as chronic failure (Berndt,
1976).
Ohata et al. (1987) noted that increases in urinary enzyme excretion
precedes other common indicators of nephrotoxicity including the increase in
urinary protein, the decrease in creatinine clearance, the elevation of serum
creatinine and blood urea nitrogen (BUN) and that the increase in urinary
excretion of enzymes correlate well with the onset of histological changes in
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renal damage caused by several nephrotoxic agents. Compared to serum
enzymes, urinary indicators in general have received little attention as
diagnostic indicators (Price, 1982). The principal reason for the slow
development is the difficulty involved with assays of enzymes in a fluid which
varies in volume, composition and which is a hostile environment for many
enzymes (Price, 1982).
The principal source of urinary enzymes is the kidney while the bladder
and urogenital tract contribute comparatively little (Price, 1982). Urinary
enzymes have been used in nephrotoxicity studies as noninvasive tests for
renal damage and elucidation of the primary site of damage along the nephron.
In addition, as excretion is dose related they can be used to assess the
nephrotoxicity of xenobiotics (Price, 1982). Urinary enzymes are most valuable
during the early acute stages of renal disease but also can provide information
on the rate of recovery (Price, 1982). Periodic determination by urinalysis is
required because the increases are transient (Ohata et al., 1987). When an
enzyme is chosen as a diagnostic indicator, its subcellular and regional location
should be known, it should be stable in urine and maintain activity under
storage conditions for a reasonable time at 4^0 (Price, 1982). In addition,
control levels of enzymes in normal serum and urine should be known.
Typically, urine is collected from animals housed in metabolism cages
and should be collected over ice. The samples should be filtered or centrifuged
to remove hair, debris, fecal and food contamination because of the presence of
enzymes in gut flora and commercial food pellets (Price, 1982). Most
importantly urinary enzyme and constituent analysis should be done on
samples collected over a finite period of time and related to urinary creatinine to
reduce intra- and inter-individual variability (Tyson et al., 1985).
It is important to be aware of conditions that may affect results such as
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collection and sampling site for serum enzyme analysis (Neptun et a!., 1985)
and collection conditions for urine enzyme analysis. The routine use of
urinalysis in rodent studies for the assessment of kidney function continues to
be limited by a need to improve collection methods and handling (Tyson et al.,
1985; Sey eta!., 1991).
It is known that there are changes in cortical and medullary metabolism
which suggests the differentiation of enzymes along the nephron (Guder and
Ross, 1984); however, no enzyme has proven to be entirely specific to a
particular region (Price, 1982). AST activity is greatest in the ascending limb
and distal convoluted tubule with considerable activity also present in the
proximal tubule. AST, a mitochondrial enzyme is found in the cytosol and
follows the mitochondrial density along the nephron (Guder and Ross, 1984).
Mitochondria are unevenly distributed along the nephron with the greatest
density in the thick ascending limb of the loop of Henle and the proximal
convoluted tubule (Guder and Ross, 1984). ALT is present in all structures in
relatively small amounts except the proximal straight tubule where it is much
higher and exceeds that of AST (Guder and Ross, 1984).
ALK PH and 5' NUC are brush border enzymes in the proximal tubule.
Their role is not well understood; it seems to be similar to that of intestinal brush
border hydrolases, namely to split peptides polysaccharides and other
molecules into reabsorbable fragments. Activity increases towards the end of
the proximal tubule (Guder and Ross, 1984). In addition, LDH is associated
with the brush border of the proximal tubular cells (Guder and Ross, 1984).
Elevation in LDH isoenzymes in the rat kidney are useful for determining renal
damage at an early stage. The distribution of isoenzymes is not homogeneous
along the nephron allowing selectively damaged regions to be differentiated
(Ohataetal., 1987).
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In a study by Stonard et al. (1987) the urinary enzyme NAG among
Others was measured as an indicator of papillary damage. When damage
occurred, NAG was elevated; thus, it is a useful diagnostic enzymes for that
region (Price, 1982). Sustained increases in urine volume and NAG activity
suggest a defect in concentrating ability and therefore also indicative of
papillary damage (Price, 1982).
Measurement of nonenzymatic urinary indicators such as total
protein, glucose, pH, albumin and osmolality can prove useful information in
assessing the functional, as opposed to biochemical, state of the kidney (Price,
1982). Urine volume is used to indicate changes in kidney load and function.
In acute renal malfunction, urine volume is either normal or reduced (oliguria)
and many well known chemicals such as CCI4 can produce this effect.
Frequently however, the initial oliguria may be superceded by a diuretic phase
(Tyson et al., 1985). Urine volume, specific gravity and color are somewhat
interdependent in that as volume increases color is paler and specific gravity
decreases (Tyson et al., 1985). In the assessment of the toxicological
significance of biochemical changes, it is important to have sufficient
background data on normal ranges of values to be expected in the strain and
species used (Tyson et al., 1985). Also, controls should accompany samples
and laboratory historical data can provide a good reference for normal ranges.
The use of urinary enzymes to monitor glomerular function suffers two
disadvantages. First there are few examples of enzymes which are specific
markers for glomeruli. Second, glomerular damage allows the passage of
normally excluded plasma enzymes into the tubular fluid which, if not
reabsorbed, appear in the urine (Price, 1982). The measurement of urinary
excretion of proteins is, however, a useful procedure for the assessment of the
glomerular integrity. The selective permeability of the glomerular membrane is
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an important aspect of normal renal function. When the selective permeability is
decreased, a common occurrence in renal failure, excessive amounts of plasma
proteins are excreted (Berndt, 1976). The first proteins to leak through the
glomerulus are albumin and alpha-globulin followed by other serum proteins as
the damage increases (Tyson et al., 1985), Not all proteinurias should be
interpreted as evidence of glomerular dysfunction, although any time an
experimental animal excretes increased amounts of protein in urine, glomerular
dysfunction is suspected (Berndt, 1976). In addition, increased protein could
be due to failure of tubular reabsorption and not glomerular damage. The
differentiation of glomerular from tubular proteinuria may be accomplished by
separation of high and low molecular weight proteins by gel filtration (Tyson et
al., 1985).
Changes in urinary pH can also be nonspecific reflecting adaption to
nonrenal physiologic abnormalities. Exposure of urine to air for extended
periods of time can render pH measurements useless (Tyson et al., 1985).
Consequently, care should be taken in the measurement and interpretation of
urine pH. It has been noted that nephrotoxic agents reduce the animal's ability
to concentrate urine, changes in urine osmolality occur early but osmolality is
not nephro-specific and usually occurs as a prelude to other events (Berndt,
1976).
The kidney contains the highest activities of enzymes involved with GSH
synthesis and degradation, all nephron cells studied contain millimolar
concentration of GSH with highest levels in the proximal straight tubule (Guder
and Ross, 1984). Thus the proximal tubule is thought to be the site of GSH
linked reactions. Cytochrome P-450 is also most prevalent in the proximal
straight tubule. Thus the coincidence of enzymes and cofactors together with
enzymes of GSH metabolism, points to the proximal tubule as an important site
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of renal drug metabolism (Guder and Ross, 1984).
III.   Materials and Methods
Animals
Male Fischer-344 rats (Charles River Laboratories, Raleigh, NC), 62-65
days old on arrival were housed 2/cage in polyethylene shoebox cages with
heat-treated pine-shavings as bedding. Two days later rats were moved to
individual plastic Nalgene metabolism cages (Nalgene Corp., Rochester, NY)
for the duration of the experiment including a 3 day acclimation period prior to
chemical treatment.
Tap water and feed (Rodent Chow no. F0165 BioServ, Results Brand,
Frenchtown NJ) were provided ad libitum. Animals were maintained under
conditions of controlled temperature of 22 +/- 2^ C, relative humidity of 50 +/-
10% and a 12 hour light-dark cycle with light from 0600 to 1800. Feed and
water consumption and body weight were monitored daily. At the end of the 3
day acclimation period, rats were assigned by body weight to one of 12
treatment groups.
Dosing
The treatment groups included dosages of 0, 0.5 or 1.0 ml CHCI3/kg, 0 or
1.0 ml TCE/kg or their factorial combinations in either corn oil or aqueous
vehicle. The solutions were administered at a constant volume of 10 ml/kg for
both the oil and aqueous vehicles. The individual chemicals and their binary
combinations were administered via a single oral gavage, CHCI3 (Aldrich,
Milwaukee, Wl, 99.8+% spectrophotometric grade, Lot No. 04201CX) and TCE
(Aldrich, Milwaukee, Wl, 99+% spectrophotometric grade, Lot No. 00723AP)
were prepared in either corn oil (Sigma, St. Louis, MO, Lot No. 80H0835) or
10% Emulphor (GAF Corp., Linden, NJ, EL-620 Lot No. 3053) in deionized
water.
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Control animals received only corn oil or 10% Emulphor. One day prior
to dosing, Emulphor-620 and deionized water were heated separately to 40^ C.
A 10% solution of Emulphor was prepared by shaking the deionized water and
Emulphor vigorously and maintaining the solution at 40^ C. Dosing solutions
were prepared in crimp top vials, sealed and shaken then placed in the water
bath for 2 hours before being removed, covered and left at room temperature
until the following morning when animals were dosed. Chemicals were
administered in a constant volume of 10 ml/kg by oral gavage with 20-gauge,
2.5 inch ball-tipped gavage needles attached to a 3.0 ml disposable syringe.
Control animals received vehicles in the same volume.
Safety  Precautions
All dosing solutions were made under the ventilated hood in the
laboratory. During animal dosing, personnel were required to wear respirators
with cartridges for removing organic vapors in addition to protective lab coats
and gloves. Dosing was performed in an animal room under negative pressure
ventilation which is restricted for VOC studies.
Experimental  Design
Twenty-four hours post exposure, rats were tail bled. Blood was collected
using serum separator tubes (Microtainer, Becton-Dickinson, Lincoln Park, NJ
Lot No. 1A671) held on ice for 30 minutes then centrifuged at 17,000 x g for 4
minutes. Serum was collected and frozen at -80^ C until analyzed. At 48 hours
rats were weighed then anesthetized with sodium pentobarbital (Nembutal,
Abbot Lab., Chicago, III), injected at 50 mg/kg ip. They were bled through the
abdominal aorta using serum separator tubes (Becton-Dickinson, Lincoln Park,
NJ). The blood was held on ice for 30 minutes then centrifuged at 1000 x g for
30 minutes. Serum was collected and frozen at -80^ C until analyzed.
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Urine Clinical Chemistry
Animals were housed in stainless-steel wire-bottomed plastic Nalgene
metabolism cages (Nalgene Corp., Rochester, NY) with a separating funnel
below to separate feces and allow urine to run down into a collecting tube.
Refrigerant ice packs (Polyform Packer Corp., Wheeler, IL) surrounded the
collection tube to keep the samples cold. A baseline urine sample was
collected for 12 hours prior to dosing in addition to collection from 0 to 6 hours,
6 to 12 hours, 12 to 24 hours 24 to 36 hours and 36 to 48 hours post gavage.
Samples were centrifuged at 800 x g for 10 minutes at 40c then poured into
clean tubes.
Osmolality, pH and volume were measured immediately following urine
collection. Remaining urine samples were held at 40C and within 24 hours of
the urine collection, urine chemistry profiles were determined by automated
procedures using a Centrifichem-500 centrifugal analyzer (Baker Instruments
Co., Allentown, PA) and appropriate reagent kits. Analysis inlcuded
determination of activities of aspartate aminotransferase (AST), alanine
aminotransferase (ALT), alkaline phosphatase (ALKPH) and lactate
dehydrogenase (LDH) and the concentrations of creatinine (CRE), urea
nitrogen (UN) and total protein. Remaining urine samples were frozen at
-400C as is or in 10% glycerol (Sigma St Louis, MO, Lot No. 10H0549).
Serum Clinical Chemistry
Serum chemistry profiles were determined by automated procedures
using a Centrifichem-500 centrifugal analyzer. Analysis included determination
of activities of aspartate aminotransferase (AST), alanine aminotransferase
(ALT), alkaline phosphatase (ALKPH), lactate dehydrogenase (LDH), sorbitol
dehydrogenase (SDH), 5' nucleotidase (5' NUC) and the concentrations of
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creatinine (CRE), blood urea nitrogen (BUN), bile acids, triglycerides (TRIG),
total billinjbin (TBILJ) on the 48 hour samples and the determination of ALT and
bile acids on the 24 hour samples. Parameters for the 24 hour samples were
selected based on expected sensitivity from preliminary experimental data and
quantity of serum required for the analysis.
Histology
The liver and kidneys of each rat were excised, rinsed in physiological
saline, blotted gently and weighed. Relative organ weights (ratio of organ
weight to sacrifice body weight) were calculated for each rat. Horizontal and
longitudinal sections of the right and left kidney, respectively, and a sample from
the left hepatic lobe of the liver were taken for open histopathological
examination (Society of Toxicologic Pathologists, 1986; Prasse et al., 1986).
Tissue sections were fixed in 10% phosphate-buffered formalin then
hematoxylin- and eosin- stained. Hepatocellular degeneration and necrosis
were evaluated and graded separately for lobular location (centrilobular,
periportal, mid-zonal) and severity according to the following criteria: none;
minimal (one to several hepatocytes affected); mild (no more than one-fourth of
the hepatocytes in the affected zone involved); moderate (expansion of the
number of damaged hepatocytes up to one-half of the affected zone); and
marked (over one-half of the lobular architecture involved) (Simmons et al.,
1988). Kidney nephropathy was graded on a scale of increasing severity as
none, minimal (scattered foci of tubular cell regeneration with affected tubules
having an increased number of cells with intense cytoplasmic and nuclear
staining with up to 25% of the cortex affected); mild (increased extent and
number of regenerative foci, basement membranes surrounding regenerative
tubules and within glomeruli thickened, tubular protein casts with 25-50% of the
cortex affected); moderate (further increases in number and severity of
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regenerative foci, increased number of tubular protein casts, increased
glomerular damage with adhesions between the glomerular tuft and perietal
epithelial cytoplasm with 50-75% of the cortex affected); and marked (diffuse
involvement of cortex, "end-stage" kidney with sufficient impairment to result in
either secondary hyperparathyroidism or contribute to death).
Statistical Methods
Analysis of variance (ANOVA) (SAS Institute, Inc., 1989) was used to
assess the statistical significance of CHCI3, TCE and vehicle effects on serum
and urinary indicators of toxicity and organ and body weights. In all cases, 0.05
was the level of significance. A Bartlett's test was performed prior to analysis
to test for the assumption of homogeneity of variance. The criterion of
significance for the homoscedasticity tests was p^ 0.001 (Anderson and
McLean, 1974). If the assumption was not satisfied, a log scale transformation
was performed to correct for heterogeneity.
A four-way analysis of variance with the factors CHCI3, TCE, vehicle and
experiment and their interactions was performed on each variable. Experiment
was included as a blocking factor to remove variability due to the effect of
experimental replication. In the majority of analyses of serum and urinary
indicators and organ and body weights, at least one interaction with vehicle
was significant. Therefore, it was necessary to perform a three-way analysis of
variance with CHCI3, TCE and experiment factors on the data for each vehicle.
In the three-way analyses of variance where CHCI3 and TCE did not
interact significantly, a Ryan(1959 and 1969)-Einot(1975)-Welsh(1977) (REW)
multiple comparison procedure was performed to assess the differences among
CHCI3 doses if that main effect was significant (p<0.05).
In the cases where CHCI3 and TCE interacted significantly, additional
analyses were performed.   A two-way analysis of variance was done on the
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data at each level of CHCI3 to determine if the difference in TCE was significant.
Also, a two-way analysis of variance was done on the data at each level of TCE
to assess differences in CHCI3. In these last two analyses if the CHCI3 effect
was significant, a REW multiple comparison procedure was done to determine
which dose levels were different from each other.
The serum indicators LDH, CRE, BUN, NUC and AST in addition to body
and organ weights were single independent measurements whereas the bile
acids and ALT were repeated measures at both 24 and 48 hours. All urinary
indicators were measured over 48 hours at a total of 6 time intervals. These
repeated measures parameters were treated separately at each time point and
consequently analyzed using the same approach as the single measure serum
indicators.
A 5-way multivariate analysis of variance for repeated measures with the
factors CHCI3, TCE, vehicle, time, experiment and their interactions was
performed on both ALT and bile acids which were measured at 24 and 48
hours. Experiment was included as a blocking factor to remove variability due to
the effect of experimental replication. Vehicle interactions were significant;
therefore, it was necessary to perform a three-way analysis of variance to
examine the effects of time on each combination of CHCI3 and TCE for each
vehicle.
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IV.   Results
Acute Hepatic Response
Chloroform Toxicity
The administration of 0.5 and 1.0 ml CHCI3/kg alone in corn oil produced
a significant decrease, compared to controls, in animal body weight 48 hours
post dosing (Figure 3). Consequently relative liver weight (liver weight/body
weight) was assessed rather than absolute liver weight. In both the 0.5 and 1.0
ml CHCI3/kg dosage groups there was a significant elevation in relative liver
weight over the control animals (Figure 5). The administration of 0.5 and 1.0 ml
CHCI3/kg in the aqueous vehicle produced a significant decrease in body
weight at 48 hours with 1.0 ml causing a significant decrease over 0.5 ml
CHCI3/kg (Figure 4). Relative liver weight, in the aqueous group, was
significantly decreased by 1.0 ml CHCI3/kg (Figure 6).
Serum enzyme indicators used for the detection of hepatic damage
included LDH, AST and 5'Nuc which were measured at 48 hours post dosing.
Additionally, ALT and bile acids were measured at both 24 and 48 hours post
dosing in order to assess the effect of time on the observed toxicity. LDH and 5'
Nuc were significantly elevated at 48 hours when 0.5 and 1.0 ml CHCI3/kg
alone were administered in oil (Figures 7 and 11). AST enzyme levels were
also significantly elevated over the control group at 0.5 and 1.0 ml CHCI3/kg in
oil with 0.5 ml CHCI3/kg causing significantly greater elevations of AST than
1.0 ml CHCI3/kg (Figure 9). When administered in the aqueous vehicle,
significant elevations in LDH and AST resulted from the 1.0 ml CHCI3/kg
dosage only (Figures 8 and 10). No significant differences in 5' Nuc were
observed following administration of CHCI3 in the aqueous vehicle (Figure 12).
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At 24 hours, ALT was significantly elevated over the control group by 0.5
and 1.0 ml CHCI3/kg alone in oil (Figures 13 and 14). Similarly, at 48 hours,
ALT was significantly elevated by both 0.5 and 1.0 ml CHCI3/kg in oil with 0.5
ml CHC!3/kg causing significantly greater levels of ALT than 1.0 ml CHCI3/kg
(Figures 13 and 14). In the aqueous vehicle, both 0.5 and 1.0 ml CHCI3/kg
alone, compared to the controls, caused significantly greater levels of ALT at 24
hours (Figures 15 and 16). At 48 hours, 1.0 ml CHCI3/kg produced a significant
elevation over controls (Figure 16). Bile acids were significantly elevated by 0.5
and 1.0 ml CHCI3/kg at both 24 and 48 hours when administered in oil.
Conversely, in the aqueous vehicle, CHCI3 caused no significant elevations in
bile acids at either time (Figures 17 - 20).
Trichloroethylene Toxicity
The administration of 1ml TCE/kg alone caused no significant changes in
body weight in either oil or aqueous solutions (Figures 3 and 4). Relative liver
weight was significantly elevated over controls in those groups receiving TCE
alone in oil (Figure 5). However, TCE had no effect on relative liver weight
following administration in the aqueous vehicle (Figure 6).
Levels of LDH, AST and 5'Nuc were not altered by 1.0 ml TCE/kg alone
in either oil or aqueous vehicle when compared to the control group (Figures 7-
12). No significant differences in ALT levels at 24 and 48 hours were observed
following administration of 1.0 ml TCE/kg alone in either vehicle when
compared to the control group (Figures 13-16). Bile acids showed no
significant differences at 24 or 48 hours relative to controls when 1.0 ml TCE/kg
was administered in the aqueous vehicle (Figures 19 and 20) or at 24 hours in
the oil vehicle (Figures 17 and 18). However, 1.0 ml TCE/kg alone caused a
significant elevation over the controls at 48 hours in the oil vehicle (Figures 17
and 18).  In addition, both 0.5 and 1.0 ml TCE/kg at 48 hours were significantly
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elevated  compared to the  24  hour values when  the  compound was
administered in the aqueous vehicle only (Figures 19-20).
Vehicle Effects
Direct vehicle comparisons were performed on the levels of ALT and bile
acids at 24 and 48 hours following administration of CHCI3 alone in oil and
aqueous vehicles. At 24 hours, ALT levels as a result of 1.0 ml CHCI3/kg were
significantly different in the two vehicles with oil causing higher elevations.
(Figure 21). At 48 hours, ALT was significantly greater when CHCI3 was
administered in the oil than in the aqueous vehicle at both 0.5 and 1.0 ml
CHCI3/kg (Figure 22). Significant vehicle differences were observed in bile
acids at 24 hours with 0.5 ml CHCI3/kg in oil causing greater toxicity (Figure
23). At 48 hours both 0.5 and 1.0 ml CHCI3/kg administered in oil produced
significantly greater levels of bile acids than aqueous vehicle administration
(Figure 24).
Differences in vehicle effects were examined indirectly in the additional
serum enzymes by examining the ratio of the response in oil to the response in
aqueous administration. Oil to aqueous ratios for LDH, AST and 5'Nuc are
presented in Table 2. Overall, the oil/aqueous ratios for AST and LDH show
greater elevation in these enzymes by all dose groups administered in the oil
vehicle. CHCI3 alone resulted in significant increases when compared to
controls in 5'Nuc when administered in oil but not when administered in the
aqueous vehicle (Figures 11 and 12). At 0.5 ml CHCI3/kg oil gavage resulted
in LDH levels more than 40-fold greater than aqueous gavage. At 1.0 ml
CHCI3/kg in oil, LDH was elevated by almost 18-fold relative to aqueous.
Similarly AST was elevated more than 110-fold when 0.5 ml CHCI3 was
administered, and 26-fold when 1.0 ml CHCI3/kg was administered, in oil
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compared to aqueous. TCE alone produced almost a 4-fold elevation in LDH
when administered in oil than aqueous; however, vehicle differences were not
apparent in AST and 5'Nuc levels when 1.0 ml TCE was administered in either
vehicle. Vehicle effects were not as great when CHCI3 is administered in the
presence of TCE; however, LDH and AST were elevated by CHCI3 in the
presence of TCE in the oil compared to the aqueous vehicle.
Interactions of Chloroform and Trichloroethylene
When both CHCI3 and TCE were administered there were no significant
differences from control animals in body weight at either concentration of
CHCI3 or in either vehicle (Figures 3 and 4). Similarly with relative liver weight,
when both chemicals were administered in either oil or aqueous vehicles no
differences from controls were observed (Figures 5 and 6).
Serum levels of LDH, AST and 5'Nuc were significantly decreased when
both CHCI3 and TCE were administered in oil relative to CHCI3 alone in oil.
This occurred at both 0.5 and 1.0 ml CHCI3/kg (Figures 7, 9 and 11). In the
aqueous vehicle, LDH, AST and 5'Nuc levels following both CHCI3 and TCE
administration were not significantly different from CHCI3 alone (Figures 8, 10
and 12).
ALT levels at 24 hours were significantly lower in the groups receiving
both CHCI3 and TCE in oil than CHCI3 alone in oil. This was observed in both
the 0.5 and 1.0 ml CHCI3/kg dosage groups (Figures 13 and 14). At 48 hours,
0.5 ml CHCI3/kg plus TCE in oil produced a significant decrease in ALT levels
relative to CHCI3 alone in oil. When administered in the aqueous vehicle, both
0.5 and 1.0 ml CHCI3/kg plus TCE significantly decreased ALT levels at both
24 and 48 hours compared to CHCI3 alone (Figures 15 and 16).
In oil, 0.5 ml CHCI3/kg plus TCE caused a significant decrease in bile
acids at both 24 and 48 hours relative to CHCI3 alone. Administration of 1.0 ml
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CHCI3/kg plus TCE produced a significant decrease at 48 hours compared to
CHCI3 alone. Although not statistically significant, the trend of decreased
toxicity was also observed at 24 hours (Figures 17 and 18). In the aqueous
vehicle, a similar trend was apparent although none of the changes were
significant (Figures 19 and 20).
Histopathological Results
When CHCI3 alone was administered in oil, the histopathological
examination at 48 hours revealed that 0.5 ml CHCI3/kg caused mild (4/6) and
moderate (1/6) centrilobular hepatic necrosis. In oil, 1.0 ml CHCI3/kg caused
mild (6/6) centrilobular hepatic necrosis. In contrast, both 0.5 and 1.0 ml
CHCI3/kg administered in the aqueous vehicle produced no observable hepatic
necrosis (Table 5).
In oil, 0.5 ml CHCI3 caused mild (1/6), moderate (3/6) and marked (2/6)
centrilobular vacuolar degeneration and 1.0 ml CHCI3/kg caused moderate
(3/6) and marked (3/6) damage. When administered in the aqueous vehicle,
0.5 ml CHCI3/kg caused minimal (5/6) vacuolar degeneration and 1.0 ml
CHCI3/kg caused minimal (4/5) and mild (1/5) damage (Table 6). TCE alone
did not produce any hepatic necrosis or vacuolar degeneration in either vehicle
(Tables 5 and 6).
When animals received oil administration of the chemicals, an apparent
reduction in lesion severity was observed in the dose groups receiving both
CHCI3 and TCE when compared to the CHCI3 alone dose group. When 0.5 ml
CHCI3/kg is administered in oil in the presence of TCE no (3/6) and minimal
(3/6) lesions were observed whereas in the absence of TCE, mild (4/6) and
moderate (1/6) hepatic necrotic lesions were observed. Exposure to 1.0 ml
CHCI3/kg in the presence of TCE produced minimal (6/6) lesions whereas in
the absence of TCE, mild (6/6) necrotic lesions were observed (Table 5).
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In the presence of TCE, 0.5 ml CHCI3/kg in oil produced lesions ranging
form minimal to moderate whereas in the absence of TCE, mild to marked
centrilobular vacuolar degeneration was observed. In the presence of TCE,
1.0 ml CHCI3/kg in oil produced mild (3/6) and moderate (3/6) lesions whereas
in the absence of TCE, moderate (3/6) and marked (3/6) lesions were observed
(Table 6). Centrilobular necrosis and vacuolar degeneration caused by the
aqueous administration of all dose groups is less severe with no apparent
observable interaction of CHCI3 and TCE (Tables 5 and 6).
In all dose groups, the vehicle effect is apparent. CHCI3, both in the
absence and presence of TCE appears to produce more severe centrilobular
necrosis and vacuolar degeneration when administered In the oil than aqueous
vehicle. This is most apparent in the observed hepatocellular necrosis where
minimal, mild and moderate lesions were observable when the chemicals were
administered in oil whereas no necrosis was observed when chemicals were
administered in the aqueous vehicle (Tables 5 and 6).
B. Acute Renal Response
Chloroform Toxicity
When CHCI3 alone was administered in the oil vehicle, both 0.5 and 1.0
ml/kg resulted in significant increases in relative kidney weight over the control
group (Figure 25). When CHCI3 alone was administered in the aqueous
vehicle, only 1.0 ml CHCI3/kg resulted in a significant elevation in relative
kidney weight (Figure 26).
Serum indicators used for the detection of renal damage included BUN
and CRE which were measured at 48 hours. Both CRE and BUN were
significantly elevated by the 0.5 and 1.0 ml CHCI3/kg dosage when
administered in the oil vehicle (Figures 27 and 29).   In the aqueous vehicle,
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BUN was significantly elevated only by the 1.0 ml CHCI3/kg dosage (Figure 28)
while CRE levels were not elevated at either CHCI3 dosage (Figure 30).
Due to the investigative nature of this study a number of urinary enzymes
and indicators of renal damage were measured, including urinary AST, ALT
and LDH as well as urea nitrogen (UN), urinary creatinine (UCRE), total protein
(TPR) and osmolality plus urine volume and pH.
Each of these parameters was measured in a baseline sample in
addition to 6, 12, 24, 36 and 48 hours post dosing. As a first step in determining
the significant differences between dosing groups, an initial analysis of variance
was performed to determine if there was any significant effect due to the vehicle
of administration. In order to reduce the number of analyses conducted, if
vehicle was not significant, further analysis was done without distinguishing
between vehicles, giving an effective N of 12/group. In those cases where
vehicle was a significant factor, dose groups were separated by vehicle before
proceeding with analysis (N=6/group). Consequently, in reporting the results, if
no vehicle distinction is made, it can be assumed that any findings apply to
both vehicles combined, otherwise, vehicle differences will be discussed.
AST was significantly elevated by 0.5 and 1.0 ml CHCI3/kg alone
administered in both oil and aqueous vehicles at 36 and 48 hours post dosing
(Figures 31 and 32). ALT was significantly elevated at 36 and 48 hours (vehicle
combined) by both-0.5 and 1.0 ml CHCI3/kg alone (Figures 33 and 34). LDH
was significantly elevated over control values at 24 hours in both vehicles, 36
hours (vehicle combined) and 48 hours in both vehicles by 0.5 and 1.0 ml
CHCI3 (Figures 35 and 36).
UCRE (Figures 37 and 38) was significantly decreased by 0.5 ml
CHCI3/kg alone (vehicle combined) at 6 hours. At 12 hours in both oil and
aqueous vehicles, both 0.5 and 1.0 ml CHCI3/kg caused a decrease compared
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to the control group. At 24, 36 and 48 hours both 0.5 and 1.0 ml CHCI3/kg
decreased the UCRE level as compared to the control values (vehicle
combined).
UN (Figures 39 and 40) was significantly elevated at 6 hours by the 1.0
ml CHCI3/kg dose (vehicle combined). At 12 hours, both 0.5 and 1.0 ml
CHCI3/kg caused an elevation in UN when administered in oil whereas in
aqueous vehicle only 1.0 ml CHCI3/kg elevated the UN level significantly above
control. At 24 hours, oil administration of 1.0 ml CHC3/kg caused a significant
elevation of UN while aqueous administration of 0.5 ml CHCI3/kg caused a
significant decrease. At 36 hours, 1.0 ml CHCI3/kg in both oil and aqueous
vehicles produced a significant elevation.
TPR (Figures 41 and 42) increased at 36 and 48 hours in the dose
groups receiving 0.5 and 1.0 ml CHCI3/kg alone in oil. At 48 hours 0.5 ml
CHCI3/kg resulted in significantly greater TPR than 1.0 ml CHCI3/kg. When
administered in the aqueous vehicle, 0.5 ml CHCI3/kg caused a significant
decrease at 24 hours in TPR when compared to controls. At 36 and 48 hours
1.0 ml CHCI3/kg in aqueous vehicle produced a significant elevation.
The osmolality (Figures 43 and 44) was decreased by 0.5 and 1.0 ml
CHCI3/kg alone at 24 and 36 hours (vehicle combined) and at 48 hours in both
vehicles. In addition, in the aqueous vehicle, decreases occurred at 12 hours in
the 0.5 and 1.0 ml CHCI3/kg dosage groups. Urine volume (Figures 45 and 46)
was significantly increased by 0.5 and 1.0 ml CHCI3/kg alone at 6 hours when
CHCI3 was administered in oil. Elevations occurred by 0.5 and 1.0 ml
CHCI3/kg at 12 and 24 hours (vehicle combined). At 48 hours when 0.5 ml
CHCI3/kg was administered in an aqueous vehicle, a significant increase in
volume was observed. pH (Figures 47 and 48) was decreased at 24 hours by
0.5 and 1.0 ml CHCI3/kg alone administered in oil and aqueous vehicles.
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Additionally, similar results were observed at 6, 36 and 48 hours in the vehicle
combined analysis.
Trichloroethylene Toxicity
In both oil and aqueous vehicles, 1.0 ml TCE/kg resulted in significant
increases in relative kidney weight (Figures 25 and 26). No differences in CRE
and BUN were observed at 48 hours in either vehicle when TCE alone was
administered relative to control (Figures 27-30). Administration of 1.0 ml
TCE/kg alone in either vehicle did not alter the enzyme levels of AST or ALT at
any time (Figures 31-34). LDH was unaffected by TCE when administered in
oil; however, a significant elevation occurred at 24 hours when TCE alone was
administered in the aqueous vehicle (Figure 36).
Administration of 1.0 ml TCE/kg alone caused minimal or no response in
the urinary indicators at each time point when compared to the control group.
The following are the indicators which were significantly altered by TCE
administration: UCRE at 12 hours when TCE was administered in aqueous
vehicle (Figure 38); TPR at 36 and 48 hours when TCE was administered in an
oil vehicle (Figure 41); osmolality at 12 hours when TCE was administered in
aqueous vehicle (Figure 44); and, pH at 6 and 24 hours when TCE was
administered in an aqueous vehicle (Figure 48).
Vehicle Comparisons
No direct vehicle comparisons were made on the indicators of renal
damage; however, oil/aqueous ratios of urinary enzymes AST and LDH are
presented in Tables 3 and 4, respectively. The urine data were variable, even in
the control values; consequently, the following is a discussion of the ratios
obtained; however, the investigator feels that vehicle effects as observed in the
urinary enzymes are very weak. At 24 hours, LDH was elevated more than 2-
fold in the aqueous vehicle when compared to the oil administration of 0.5 and
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1.0 ml CHCI3/kg alone. At 36 hours however, the vehicle effect was reversed
with 0.5 ml CHCI3/kg alone resulted in almost a 2-fold elevation in LDH when
administered in oil. The response of LDH at 36 hours to 1.0 ml CHCI3 alone did
not appear to be affected by vehicle. At 48 hours, 0.5 ml caused a 4-fold
elevation and 1.0 ml CHCI3/kg resulted in a 1.3-fold elevation in LDH when
administered in oil vs aqueous vehicle. Levels of LDH did not appear to be
greatly affected by vehicle when TCE was administered. The interaction of
CHCI3 and TCE resulted in slightly higher elevations when administered in oil
vs aqueous vehicles at 36 hours and 48 hours when 0.5 and 1.0 ml CHCI3/kg
were administered. Conversely, at 24 hours the aqueous vehicle produced a
greater elevation in LDH from exposure to 0.5 and 1.0 ml CHCI3 in the
presence of TCE.
AST was elevated by 0.5 and 1.0 ml CHCI3/kg alone by almost 3-fold
when administered in aqueous compared to oil at 24 hours. In contrast, 0.5 and
1.0 ml CHCI3/kg elevated AST at both 36 and 48 hours by 1.3 to 4.5-fold when
administered in the oil vehicle. TCE alone appeared to elevate AST at 24, 36
and 48 hours when administered in the oil compared to the aqueous vehicle
(Table 3). At 24 and 36 hours, 0.5 ml CHCI3/kg plus TCE in either vehicle
caused a similar response in AST whereas 1.0 ml in oil in the presence of TCE
elevated AST by more than 2-fold. At 48 hours, the administration of 0.5 ml
CHCI3 in the presence of TCE resulted in a 2-fold elevation in AST when
administered in the aqueous vehicle, whereas 1.0 ml CHCI3 plus TCE
produced a greater than 4-fold elevation, occurring when the chemicals were
administered in oil (Table 3).
Interactions of Chloroform and Trichloroethylene
In the presence of TCE, 0.5 ml CHCI3 in oil significantly increased
relative kidney weight when compared to controls; however, 0.5 ml CHCI3/kg in
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oil in the absence of TCE caused a significantly greater increase when
compared to CHCIS plus TCE (Figure 25). In the presence of TCE, BUN was
elevated following 1.0 ml CHCI3/kg in oil; however, this was not significantly
different from 1.0 ml CHCI3 in the absence of TCE (Figure 27). In contrast,
when CHCIS was administered in oil in the absence of TCE, both 0.5 and 1.0 ml
CHCI3/kg were significantly elevated relative to controls (Figure 27). CHCI3, in
the presence of TCE, did not elevate BUN relative to controls when
administered in the aqueous vehicle; however, 1.0 ml CHCI3/kg in the absence
of TCE elevated BUN significantly relative to controls (Figure 28).
When administered in oil in the presence of TCE, no significant
elevations in CRE resulted from 0.5 ml CHCI3/kg when compared to controls. In
contrast, in the absence of TCE, 0.5 ml CHCI3/kg significantly elevated CRE
relative to controls. In addition, the CRE concentration resulting from CHCI3 in
the presence of TCE was significantly less than the CRE concentration resulting
from CHCI3 in the absence of TCE (Figure 29). In the presence of TCE, CRE
was significantly elevated by 1.0 ml CHCI3/kg in oil relative to controls;
however, this was not significantly different from 1.0 ml CHCI3 in the absence of
TCE (Figure 29). The aqueous administration of CHCI3 either in the presence
or absence of TCE had no significant effect on CRE (Figure 30).
In the presence of TCE, AST was elevated by 1.0 ml CHCI3/kg in oil at 48
hours when compared to controls. At 36 hours in both oil and aqueous vehicles
and at 48 hours in oil vehicle, AST levels resulting from 0.5 and 1.0 ml
CHCI3/kg in the presence of TCE were significantly decreased relative to
CHCIS in the absence of TCE. Similarly at 48 hours in the aqueous vehicle,
ALT levels following 1.0 ml CHCIS/kg in the presence of TCE were significantly
decreased when compared to 1.0 ml CHCI3/kg in the absence of TCE (Figures
31 and 32).
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In vehicle combined analysis, 0.5 and 1.0 ml CHCI3/kg in the presence of
TCE resulted in significantly decreased ALT at 36 hours when compared to
CHCI3 in the absence of TCE . Although not statistically significant, similar
trends were seen in ALT at 48 hours (Figures 33 and 34).
At 24 hours, 0.5 ml CHCI3 in oil in the presence of TCE, resulted in
significantly lower LDH levels than 0.5 ml CHCI3/kg in the absence of TCE At
36 hours (vehicle combined), in the presence of TCE, 0.5 and 1.0 ml CHC13/kg
resulted in significantly lower LDH levels when compared to 0.5 and 1.0 ml
CHCI3/kg in the absence of TCE (Figures 35 and 36). At 48 hours,
administration of 0.5 and 1.0 ml CHCI3/kg in oil in the presence of TCE resulted
in significantly decreased LDH relative to CHCI3 in the absence of TCE. At 48
hours, when CHCI3 in the presence of TCE was administered in the aqueous
vehicle, no significant elevations in LDH were observed, whereas CHCI3 in the
absence of TCE produced significant increases in LDH (Figures 35 and 36).
At all time points, CHCI3 doses administered in the presence of TCE did
not produce a significantly different response from control values or CHCI3 in
the absence of TCE in UCRE and volume in both vehicles and osmolality in oil
whereas in the absence of TCE, CHCI3 administration produced significant
differences from the control values in these parameters (Figures 37, 38, 43, 45
and 46).
In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg in oil produced a
significant elevation of UN over control values at 36 hours At 0.5 ml CHCI3 in
the presence of TCE, a significantly greater elevation of UN occurred than in
the absence of TCE. When administered in the aqueous vehicle, 1.0 ml
CHCI3/kg in the presence of TCE resulted in significantly lower levels of UN at
36 hours when compared to 1.0 mi CHCI3 in the absence of TCE (Figures 39
and 40).
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Total protein was significantly decreased at 12 hours by 1.0 ml CHCI3/kg
in the presence of TCE (vehicles combined) when compared to both the TCE
control (0.0 ml CHCI3/kg/1.0 ml TCE/kg) and 1.0 ml CHCI3 in the absence of
TCE. At 36 hours in both oil and aqueous vehicles and 48 hours in oil, in the
presence of TCE, both 0.5 and 1.0 ml CHCI3/kg caused a significant decrease
in TPR compared to the CHCI3 doses alone. In contrast, 0.5 and 1.0 ml
CHCI3/kg in the absence of TCE caused a significant elevation of TPR over
controls. At 36 hours, 0.5 and 1.0 ml CHCI3/kg in oil, in the presence of TCE,
significantly decreased TPR compared to 1.0 ml TCE/kg alone. When
administered in the aqueous vehicle, 1.0 ml CHCI3 in the presence of TCE,
produced significantly lower TPR levels than CHCI3/kg in the absence of TCE
which resulted in significant elevations in TPR at 48 hours compared to controls
(Figures 41 and 42).
Administration of 1.0 ml CHCI3/kg in aqueous vehicle in the presence of
TCE, resulted in a significant increase in osmolality at 12 hours compared to
CHCI3 alone. In contrast, 1.0 ml CHCI3/kg in the aqueous vehicle, in the
absence of TCE, resulted in a significant decrease in osmolality compared to
controls. No other differences in the CHCI3 doses at the TCE levels were
observed in the measurement of osmolality (Figures 43 and 44).
At 24 hours, in the presence of TCE, 0.5 ml CHCI3/kg in oil resulted in a
significant elevation In pH compared to this CHCI3 dosage alone. In contrast,
administration of 0.5 ml CHCI3/kg in oil, in the absence of TCE, produced a
significant decrease in pH compared to controls. Additionally, 1.0 ml CHCl3/kg
in oil in the presence of TCE produced a significantly lower pH than the TCE
control. When administered in the aqueous vehicle, 1.0 ml CHCI3/kg in the
presence of TCE, resulted in a significant elevation in pH relative to the CHCI3
alone. In contrast, 1.0 ml CHCI3/kg in the absence of TCE resulted in a
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significant decrease in pH at 24 hours relative to controls. At 36 hours, 0.5 and
1.0 ml CHCI3/kg (vehicles combined), in the presence of TCE, caused a
significant decrease in pH when compared to the control. In the absence of
TCE, 0.5 and 1.0 ml CHCI3/kg also resulted in decreases in pH; however, these
were not significantly less than the decreases resulting from CHCI3 in the
presence of TCE. At 48 hours, 0.5 and 1.0 ml CHCI3/kg (vehicle combined) in
the presence of TCE produced a significant decrease in pH compared to
controls. In the absence of TCE, 0.5 and 1.0 ml CHCI3/kg also resulted in
decreases in pH; these decreases were significantly less those resulting from
CHCi3 in the presence of TCE. In summary, in the presence of TCE, CHCI3
produced a significantly higher pH (closer to controls) when compared to
CHCI3 in the absence of TCE (Figures 47 and 48).
Histopathological  Results
In oil, administration of 0.5 ml CHCI3/kg alone, resulted in mild (2/6),
moderate (1/6) and marked (2/6) renal tubule degeneration. Moderate (4/6)
and marked (2/6) damage occurred following 1.0 ml CHCI3/kg. When
administered in the aqueous vehicle, 0.5 ml CHCI3/kg resulted in no (3/6)
minimal (2/6) and mild (1/6) lesions with 1.0 ml CHCI3/kg causing minimal (2/5),
mild (1/5) and moderate (2/5) damage (Table 7). In oil, 0.5 ml CHCI3/kg
resulted in minimal (3/6), mild (1/6) and moderate (2/6) renal tubule necrosis. At
1.0 ml CHCI3/kg minimal (2/6), mild (2/6) and moderate (1/6) damage occurred.
When administered in the aqueous vehicle, 0.5 ml CHCI3/kg resulted in no (5/6)
and mild (1/6) lesions with 1.0 ml CHCI3/kg causing minimal (3/5), mild (1/5)
and moderate (1/5) damage (Table 8). TCE alone was not observed to produce
any renal tubule necrosis or degeneration in either vehicle (Tables 7 and 8).
Little if any effect of CHCI3 and TCE interactions are observed in renal
tubule degeneration; however, the interaction is evident in renal necrotic
- ^^'"SS'^TS^^wi"- i^^'?
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lesions. In the absence of TCE, 0.5 ml CHCI3/kg produced minimal (3/6), mild
(1/6), and moderate (2/6) renal tubule necrosis whereas in the presence of TCE
a minimal lesion was observed in only one animal and 5 animals had no
necrosis. In the absence of TCE, 1.0 ml CHCI3/kg in oil produced minimal
(2/6), mild (2/6) and moderate (1/6) renal tubule necrosis whereas in the
presence of TCE, no (3/6) minimal (2/6) and mild (1/6) necrotic lesions were
observed (Table 8).
In the aqueous vehicle in the absence of TCE, 0.5 ml CHCI3/kg resulted
in mild renal tubule necrosis in one animal. In the presence of TCE, no necrotic
lesions were observed. In the aqueous vehicle in the absence of TCE, 1.0 ml
CHCI3/kg produced minimal (3/5), mild (1/5) and moderate (1/5) necrosis
whereas in the presence of TCE no necrotic lesions were observed (Table 8).
Vehicle effects are apparent in the renal histological damage. Vehicle
differences appear to be more apparent in renal tubule degeneration than
necrosis. However CHCI3, both in the absence and presence of TCE, appears
to produce more severe renal tubule necrosis and degeneration when
administered in the oil than in the aqueous vehicle. One exception is the renal
tubule necrosis at 1.0 ml CHCI3/kg alone where the lesions produced by the
chemical administration in both vehicles are similar.
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V.    Discussion
A.   Cliloroform Hepatotoxiclty
Observations from the present study indicate that exposure of male F-344
rats by oral gavage to 0.5 and 1.0 ml CHCIS/kg alone in both oil and aqueous
vehicles resulted in acute hepatotoxiclty. ALT, a reliable and sensitive indicator
of hepatotoxiclty, found to correlate well with histological lesions (Zimmerman
1982, Plaa, 1982), was elevated more than 8-fold over controls at 24 hours
when 0.5 and 1.0 ml CHCI3/kg were administered in oil. At 48 hours, ALT
levels exceeded those at 24 hours, with almost a 200-fold elevation resulting
from 0.5 ml CHCI3/kg in oil and over a 100-fold elevation from 1.0 ml CHCI3/kg
in oil. When CHCI3 was administered in the aqueous vehicle increases of ALT
ranged from 3- to almost 5-fold at 24 hours. ALT levels produced by 1.0 ml
CHCI3/kg at 48 hours, although significantly elevated over controls, were less
than those at 24 hours indicating that the peak hepatotoxiclty, when CHCI3 was
administered in the aqueous vehicle, appeared to be 24 hours. Conversely,
toxicity was greatest at 48 hours when CHCI3 was administered in oil. In
addition, increased serum bile acids, an indicator of cholestatic damage
(Gopinath et al., 1980) occurred at 24 hours (9-12 fold) and to a greater extent
at 48 hours (58-73 fold) when oil was the vehicle of administration. However,
no elevations in serum bile acids occurred when CHCI3 was administered in
the aqueous vehicle.
Additionally, other serum enzymes measured at 48 hours including LDH
and AST, enzymes reflecting cytotoxic damage (Zimmerman, 1982) and 5'Nuc
(indicative of cholestasis) (Piaa and Hewitt, 1982) were elevated when CHCI3
was administered in an oil vehicle when compared to aqueous vehicle
administration.  LDH, AST and 5' Nuc were elevated 45- to 48-fold, 88- to 146-
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fold and 2- to 3-fold, respectively, over controls when CHCI3 was administered
in oil. However, in the aqueous vehicle, elevations were 2.8 fold for LDH, 1- to
3-fold for AST with no elevation in 5' Nuc.
Borzelleca et al. (1990) administered 0.47 ml CHCI3/kg (700 mg/kg) in 5
% Emulphor (10ml/kg dosing volume) to male Sprague-Dawley rats and took
serial blood samples over 72 hours. They noted an approximate 2.5-fold
elevation in ALT and an approximate 1.75-fold elevation in AST and that peak
toxicity occurred at 36 hours, in the aqueous vehicle, elevations of ALT and
AST at 24 hours in the present study were similar to the values obtained by
Borzelleca et al. at 36 hours. Differences may be the result of the animals being
cannulated for serial blood sampling or the fasting of animals prior to dosing in
the study by Borzelleca; additionally, they used a different strain of rats. In
another study, Steup et al. (1991) examined the toxicity of an ip administration
of 0.2 ml CHCI3/kg (298 mg/kg) in oil (2.0 ml/kg dosing volume) in F-344 rats.
The investigators observed an approximately 8-fold elevation in levels of ALT
24 hours post dosing. This value is similar to that observed for 0.5 ml CHCI3 in
the present study. Higher values may have been due to the ip injection route of
exposure vs oral gavage used in this study. Harris et al. (1982) administered
0.2 ml CHCI3/kg ip as a 30% solution in corn oil to male Long Evans rats and
obsen/ed no significant elevations in ALT 24 hours post dosing.
Serum enzyme indicators as well as histopathological evidence, useful
for specific evaluation of liver injury (Plaa and Hewitt, 1982), confirm the acute
hepatotoxicity of CHCI3 in this study and suggest that the severity of
hepatotoxicity is dependent upon the vehicle of administration.
Vehicle effects were of interest since these chemicals are common
drinking water contaminants. Also, the majority of toxicity studies have
previously been carried out in oil-based solutions; thus, it was thought that a
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direct vehicle comparison of CHCI3 toxicity and CHCI3 and TCE interactions
would be of interest. Additionally, recent findings indicate that the dosing
vehicle may significantly influence the acute toxicity of halocarbon VOCs
including carbon tetrachloride (Kim et al., 1990a) and 1,1 dichloroethylene
(Chieco et al., 1981).
Withey et al. (1983) studied the effects of vehicles on the uptake of TCE
and CHCI3 among other VOCs from the Gl tract of the rat. Higher Cmax values
were observed for both TCE and CHCI3 when administered in the aqueous
vehicle vs an oil administration (Table 9). Thus, uptake was observed to be
more rapid from aqueous solutions when equivalent amounts were
administered in oil and aqueous solutions. Additionally if unmetabolized,
CHCI3 could be eliminated by exhalation. Consequently, exhalation of
unmetabolized CHCI3 may occur more readily from the aqueous solution
accounting for the reduced toxicity when administered in the aqueous vehicle.
Whereas, when administered in oil, the compounds are not as readily exhaled
allowing a slow absorption of the chemicals into the system resulting in
metabolism of a larger portion of the dose (Burnett et al., 1992).
Kim et al. (1990b) studied the pharmacokinetics of the uptake of CCI4
from different vehicles of administration (Table 10). Kim et al. noted significantly
higher Cmax values when CCI4 was administered in the aqueous vehicles vs
the oil and concluded that an overall delay in the uptake occurred when the
chemical was administered in corn oil. In a companion study by Kim et al.
(1990a), it was observed that acute hepatic toxicity from administration of CCI4
was more pronounced when given in an aqueous vehicle than in the oil vehicle.
Substantial vehicle effects were observed in the present study; however, in
contrast to the increased hepatotoxicity of CCI4 observed in the aqueous
vehicle, CHCI3 was significantly more acutely hepatotoxic when administered
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in the oil vehicle. Thus, CCI4 and CHCI3 appear to have opposing correlations
with blood concentrations (Cmax) and resulting acute hepatotoxicity. This may
be a result of the specific pathways of metabolism and detoxification involved in
CHCI3 and CCI4 metabolism. Additionally, the relationship between the
kinetics of chemical absorption into the systemic circulation and saturation of
metabolic pathways may aid in predicting vehicle effects on toxicity.
Consequently, it appears that the influence of vehicles on uptake into the
systemic circulation, the application of pharmacokinetic data such as Cmax and
the correlation between blood concentration and hepatotoxicity require careful
examination.
B.   Chloroform Nephrotoxicity
Many in vitro studies have addressed CHCI3 nephrotoxicity (Smith et al.
1985; Smith and Hook, 1983); however, little information is available in the
literature on CHCI3 nephrotoxicity in oil and aqueous vehicles in vivo. A study
by Branchflower and Pohl (1981) examined CHCI3 nephrotoxicity in F-344 rats.
Twenty-four hours after administration of 0.5 ml CHCI3/kg ip to sesame oil
pretreated rats no significant elevation in BUN over oil controls was evident.
In the present study, acute dose-dependent CHCI3 nephrotoxicity was
observed in both oil and aqueous vehicles. Histological examination, a useful
method for detecting chemically-induced renal damage and for elucidating the
site of damage, was used to evaluate nephrotoxicity (Ohata, 1987). Renal
tubule degeneration and necrosis were apparent in both vehicles; however, oil
administration appeared to be more acutely nephrotoxic. Ohata et al. (1987)
also noted that increases in urinary enzymes precede other common indicators
of toxicity such as creatinine clearance, serum creatinine and BUN and that
enzymes correlate well with histological changes.   Thus, in addition to the
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histological lesions, other indicators of renal damage including urinary AST,
LDH and TPR are suggestive of distal convoluted tubule, proximal straight
tubule and glomerular damage respectively (Guder and Ross,1984; Berndt,
1976)
The influence of vehicles on the urinary enzymes was minimal if any.
However, when examining the severity of the histopathological lesions
including both renal tubule degeneration and necrosis, it is apparent that
CHCI3 was more acutely nephrotoxic when administered In oil compared to the
aqueous vehicle.
C.    Trichloroethylene Hepatotoxicity
In the present study, no hepatic toxicity was observed from the
administration of TCE. A significant elevation over control in relative liver
weight was observed when TCE was administered in oil; however, no necrosis
was observed upon histological evaluation of the liver tissue. This was
expected as it was the objective of this study to examine the interaction of a
nonhepatotoxic dose of TCE on both the hepato- and nephro-toxicity of CHCI3.
Similarly, Pessayre et al. (1982) noted that liver histology was normal 24 hours
after the administration of 1 ml TCE/kg ip in liquid parafin to male Sprague-
Dawiey rats; additionally, no significant elevation in ALT was observed.
D.    Trichloroethylene Nephrotoxicity
In the present study, elevations in urinary enzymes or indicators of
nephrotoxicity were not observed when TCE was administered. Relative kidney
weight was significantly increased over control in both vehicles; however, no
histological evidence of renal toxicity was observed.
Chakrabarti and Tuchweber (1988) studied the acute nephrotoxic
potential of TCE in male F-344 rats. Rats were pretreated with phenobarbital
(80mg/kg ip for 3 days) then 0, 0.49, 0.99 and 1.97 ml TCE/kg was administered
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ip in corn oil. Treatment of rats with up to 0.99 ml/kg did not influence any of the
measured biochemical parameters at 24 hours. TCE at 1.97 ml /kg was
observed to elevate NAG, BUN and glucose and an apparent saturation of
metabolism was observed. Thus, the investigators concluded that TCE exerts
acute nephrotoxicity at very high dose levels.
E. Interactions of Chloroform and Trichloroethylene on Hepatotoxicity
There are a number of studies in the literature discussing the synergistic
interaction of CCI4 and CHCI3 (Borzelleca et al., 1990; Harris et al., 1982;
Steup et al., 1991) and the synergistic interaction of CCI4 and TCE (Borzelleca
et al., 1990; Steup et al., 1991); however, no studies were found in which the
interaction of CHCI3 and TCE was examined. In contrast to the increased
hepatotoxicity seen with CCI4 and TCE it was observed in this study that the
concurrent administration of CHCI3 and TCE resulted in significantly less
hepatotoxicity when compared to that caused by CHCI3 alone. The inhibition of
toxicity by TCE can be observed in the decreased levels of AST, LDH, 5'Nuc at
48 hours, ALT and bile acid at 24 and 48 hours and in the histological lesions.
Additionally, the inhibition was observed to be independent of dose, time or
vehicle.
Both CHCI3 and TCE are known to be metabolized by the liver mixed-
function oxidase system (Pohl, 1979; Miller and Guengerich, 1983; Rouisse and
ChakrabartI, 1986). Moslen et al. (1977) studied the deactivation of P-450 by
TCE in phenobarbital-pretreated Sprague-Dawley rats exposed to 1 % (10,000
ppm) TCE by inhalation for 24 hours. The investigators found significantly
decreased P-450 in the pretreated rats after 1, 2 and 8 hours of exposure by
Inhalation to TCE. Brady et al. (1989) performed a study elucidating that the
specific P450 isozyme responsible for the oxidative metabolism of CHCI3 is IIEI
(CYP2E1).   Brady et al. demonstrated that CHCI3 metabolism was reduced
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when HE! was inhibited by diallyl sulfide. Andersen et al. (1987) examined the
metabolic interactions of TCE and 1,1 dichloroethylene, two compounds
metabolized by single saturable oxidative pathways with high-affinity substrate
binding. It was observed that the kinetic interactions in the metabolic pathways
were strictly competitive thus explaining the inhibition of metabolism when
coexposed. Andersen noted that the efficacy as an inhibitor in vivo is
dependent both on binding constants and tissue solubilities and that TCE has
high solubility in all tissues and blood. In a study by Gargas et al. (1988) on the
solubilities of halomethanes, he reported tissue:air partition coefficients of
several compounds (Table 11). TCE and CHCI3 have similar values for blood
and liver tissue indicating that both compounds readily enter the tissue.
Therefore, a possible explanation for the inhibition of CHCI3 toxicity in
the presence of TCE is that the P450 is deactivated by TCE thus inhibiting the
CHC13 metabolism to its reactive intermediates. Another possibility is that the
TCE competitively binds to the P450; thus, blocking the CHCI3 metabolism.
If TCE competitively binds or deactivates P450, this could lead to increased
exhalation of unmetabolized CHCI3 and consequently, decreased toxicity.
F. Interactions of Chloroform and Trichloroethylene on Nephrotoxicity
The inhibition of CHC13 toxicity by TCE observed in the liver was also
apparent in the kidney. Renal tubule necrosis was more severe when CHCI3
was administered in the absence of TCE when compared to the presence of
TCE. Urinary enzymes AST and LDH were also observed to significantly
increase when CHCI3 was administered in the absence of TCE. Conversely, a
significant decrease, relative to CHCI3 alone, is observed when CHCI3 was
administered in the presence of TCE. Total protein concentrations were
elevated over controls when CHCI3 was administered alone compared to no
significant elevation in the presence of TCE. These interactions were observed
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to be independent of vehicle and occurred primarily at 36 and 48 hours in both
vehicles.
It has been noted that the activation of CHCI3 by oxidative dechlorination
to phosgene may not occur in the kidney as it does in the liver since kidney
GSH is not depleted (Docks and Krishna, 1976). Additionally, CHCI3 does not
appear to be metabolized as extensively by P450 in the kidney when compared
to the liver (Docks and Krishna, 1976). This suggestion was supported by the
observation that the severity of CHCI3 nephrotoxicity in vitro did not differ
between the F-344 and Sprague Dawley rats although the concentration of
renal P450 has been shown to be two-fold greater in the F-344 strain (Smith et
a!., 1985).
Consequently, it was thought that the metabolism of CHCI3 and TCE in
the liver in the present study could be responsible for the observed effects in the
kidney; however, in a study by McMartin et al. (1981) that issue was addressed.
The investigator administered 0.45 g CHCI3/kg in corn oil (6% v/v) by gavage to
examine the effects of P450 on hepatic and renal necrosis. McMartin found no
correlation between the effects of cadmium, phenobarbital or fasting
pretreatments in increasing or decreasing hepatic cytochrome P450
concentrations and increasing or decreasing renal necrosis. Thus, suggesting
that the renal necrosis is a result of CHCI3 metabolism in the kidney rather than
the liver.
These possible differences of CHCI3 metabolism In the liver and kidney
complicates the explanation of the interactive effects seen by the inhibition of
CHCI3 toxicity by TCE in both organs. This is an area that warrants further
study in order to explain the interactive toxicity observed in both liver and kidney
tissue.
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VI.    Conclusions
CHCI3 was observed to produce a concentration-dependent increase in
hepatic and renal toxicity while TCE alone produced no overt toxicity in either
organ. It was also noted that corn oil appeared to enhance the acute hepatic
and nephrotoxicity of CHCI3. Vehicle effects appeared to be independent of
dose and time as they were observed at both 24 and 48 hours with 0.5 and 1.0
ml CHCI3/kg in both the liver and kidneys. Greater hepatotoxicity appeared to
occur at 48 hours when CHCI3 was administered in oil whereas the aqueous
vehicle appears to exhibit more or equal toxicity at 24 compared to 48 hours.
Additionally, based on severity of the histopathological lesions CHCI3
appeared to be more acutely nephrotoxic when administered in the oil
compared to the aqueous vehicle.
In the studies by Kim et al. (1990a and b), a correlation between a high
Cmax and aqueous administration of CCI4-induced hepatotoxicity was evident.
Cmax was also high when CHCI3 was administered in an aqueous vehicle
when compared to oil (Withey et al., 1983); however, it was found to be more
hepato- and nephrotoxic when administered in the oil vehicle. It appears that
the rate of uptake and absorption plays an important role in the toxicity
produced when a compound is administered. As a result of the apparent
opposing correlations of blood concentrations and acute hepatotoxicity of CCI4
and CHCI3, two structurally similar halocarbons, it seems elucidation of the
underlying mechanism of vehicle effects is crucial to more accurate risk
assessment and that further assessment of the relationship between blood
concentration and both hepatic and renal toxicity is of interest.
It is becoming more apparent that the potentially confounding effects of
the vehicle of chemical administration and route of exposure should be
6 7
examined. Additionally, an understanding of the importance of studying the
toxic effects of a contaminant in the media in which exposure is most likely ta
occur is becoming a more relevant issue as the influences of vehicles are being
observed. This is especially applicable to the VOCs since they are very
lipophilic and recent findings indicate significant vehicle alterations in
pharmacokinetics and toxicity.
The purpose of this work is to ultimately lead to an better understanding
of the risks of human exposure to interactions of VOCs in drinking water.
Mixture toxicology is a new and complex field. There are infinite combinations
of mixtures that could be tested and it would an impossibility to begin to do so.
Thus, if the mechanism(s) of the toxicity can be elucidated or if chemicals can
be grouped according to structural properties or toxic endpoint(s), it would
reduce the amount of testing required.
Examples of binary mixture interactions include the potentiation of CCI4
by TCE and the synergism of CCI4 and CHCI3 (Borzelleca et al., 1990; Steup et
al., 1991). In the present study, concurrent exposure to CHCI3 and TCE
produced significant decreases in toxicity relative to CHCI3 alone. This
inhibition of CHCI3 toxicity by TCE was observed to be independent of dose,
vehicle and time and was observed in both the liver and kidney. Thus, this
study in combination with others (Borzelleca et al., 1990; Steup et al., 1991;
Simmons et al., 1992) provides an example of the opposing interaction of TCE
on both CHCI3 and CCI4 and the opposite responses of two structurally similar
binary mixtures.
Toxicological assessment of chemical interactions is a difficult task. It is
important not only to assess the biological effects of exposure to chemical
mixtures but also the pharmacokinetic influences (Andersen et al., 1987) as well
as determining the mechanism(s) of interaction.  This information could aid in
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the interpretation of the chemical interactions which ultimately may lead to more
accurate assessments of the health risk associated with multiple chemical
exposures.
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Table 1  Legend for Explanation of Statistical Symbols
* In the absence of TCE, the CHCI3 dose is significantly different from the
controls (0.0 ml CHCI3/kg/0.0 ml TCE/kg).
< In the absence of TCE, the CHCI3 dose is significantly different from both
the control (0.0 ml CHCI3/kg/0.0 ml TCE/kg) and the low CHCI3 dose.
+ In the presence of TCE, the CHCI3 dose is significantly different from the
controls (0.0 ml CHCI3/kg/1.0 ml TCE/kg).
# In the presence of TCE, the CHCI3 dose is significantly different from both
the control (0.0 ml CHCI3/kg/1.0 ml TCE/kg) and the low CHCI3 dose.
The TCE levels, at the same level of CHCI3, are significantly different.
3 There is a significant difference between the vehicles.
$   24 hour value is significantly different from the 48 hour value.
TIME Vehicle was not significantly different and statistical analysis was
performed without making that distinction.
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0.0/0.0 154.7 149.2 1.0
0.0/1.0 498.5 135.3 3.7
0.5/0.0 6958.3 155.3 44.8
0.5/1.0 389.3 166.5 2.3
1.0/0.0 7387.7 420.0 17.6
1.0/1.0 529.3 168.2 3.2









0.0/0.0 60.2 61.3 1.0
0.0/1.0 74.2 56.5 1.3
0.5/0.0 8756.7 79.5 110.1
0.5/1.0 367.5 54.0 6.8
1.0/0.0 5267.2 200.8 26.2
1.0/1.0 980.3 74.0 13.2









0.0/0.0 48.7 87.50 1            °'^
0.0/1.0 89.4 96.2 0.9
0.5/0.0 120.9 63.7 1.9
0.5/1.0 63.0 56.0 1.1
1.0/0.0 163.4 58.0 2.8
1.0/1.0 80.0 53.4 1.5
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Table 3. Normalized AST* in Urine: Oil/Aqueous Ratios
CHCI3/TCE
(ml/kg)
Ohr 6hr 12 hr 24 hr 36 hr 48 hr  1
0.0/0.0 oil 0.09 0.12 1.24 0.21 0.12 0.19
aqueous 0.24 0.41 0.17 4.22 0.13 0.16
ratio 0.38 0.30 7.20 0.05 0.87 1.19
0.0/1.0 oil 0.10 0.15 0.11 0.33 0.16 0.27
aqueous 0.11 0.17 0.16 0.22 0.11 0.14
ratio 0.94 0.91 0.68 1.49 1.43 1.90
0.5/0.0 oil 0.10 0.23 0.21 0.47 2.75 4.00
aqueous 0.11 0.14 0.20 1.12 0.87 0.89
ratio 0.90 1.68 1.05 0.42 3.16 4.48
0.5/1.0 oil 0.24 0.60 0.14 0.18 0.16 0.33
aqueous 0.15 0.15 0.13 0.19 0.16 0.59
ratio 1.54 3.94 1.05 0.99 1.01 0.57
1.0/0.0 oil 0.10 0.16 0.16 0.18 3.46 3.74
aqueous 0.06 0.15 0.21 0.49 2.63 2.95
ratio 1.48 1.03 0.75 0.37 1.32 1.27
1.0/1.0 oil 0.06 0.56 0.29 0.42 0.29 0.92
aqueous 0.17 0.12 0.11 0.19 0.14 0.20
ratio 0.36 4.87 2.52 2.26 1   2.02 j   4.56
'Expressed as IU/10 mg UCRE
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Table 4. Normalized LDH* in Urine: Oil/Aqueous Ratios
CHCI3/TCE
(ml/kg)
Ohr 6hr 12 hr 24 hr 36 hr 48 hr  1
0.0/0.0 oil 0.338 0.347 0.778 0.424 0.294 0.285
aqueous 0.375 0.442 0.393 0.310 0.321 0.333
ratio 0.901 0.785 1.980 1.368 0.916 0.856
0.0/1.0 oil 0.355 0.427 0.520 0.454 0.364 0.304
aqueous 0.381 0.477 0.678 0.488 0.323 0.324
ratio 0.932 0.895 0.767 0.930 1.127 0.938
0.5/0.0 oil 0.357 0.491 0.551 1.019 3.128 6.364
aqueous 0.361 0.438 0.624 2.408 1.778 1.520
ratio 0.989 1.121 0.883 0.423 1.759 4.187
0.5/1.0 oil 0.355 0.487 0.556 0.417 0.681 0.809
aqueous 0.351 0.527 0.570 0.577 0.434 0.379
ratio 1.011 0.924 0.975 0.723 1.569 2.135
1.0/0.0 oil 0.367 0.550 0.576 0.620 3.770 6.241
aqueous 0.374 0.532 0.699 1.413 4.203 4.495
ratio 0.981 1.034 0.824 0.439 0.897 1.388
1.0/1.0 oil 0.367 0.445 0.519 0.515 0.708 1.337
aqueous 0.303 0.432 0.626 0.595 0.452 0.572
ratio 1.211 1.030 0.829 0.866 1.567 2.337
'Expressed as IU/10 mg UCRE
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Table 5. Centrilobular Hepatocellular Necrosis







* Each digit is the lesion score from one animal and indicates severity of
damage as described in the methods section: 0=no lesions observed;
1=minimal; 2=mild; 3=moderate; 4=marked.
**One animal died
Table 6. Centrilobular Vacuolar Degeneration







Each digit is the lesion score from one animal and indicates severity of
damage as described in the methods section: 0=no lesions observed;
1=minimal; 2=mild; 3=moderate; 4=marked.
**One animal died
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Table?. Renal Tubule Degeneration







* Each digit is the lesion score from one animal and indicates severity of
damage as described in the methods section: 0=no lesions observed;
1=minimai; 2=mild; 3=moderate; 4=marked.
**One animal died
Tables. Renal Tubule Necrosis







Each digit is the lesion score from one animal and indicates severity of
damage as described in the methods section: 0=no lesions observed;
1=minimal; 2=mild; 3=moderate; 4=marked.
"One animal died
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Table 9.   Withey et al. 1983, Pharmacokinetic Data on 75 mg
CHCI3/kg and 18 mg TCE/kg in Oil and Aqueous Vehicles





(ug/ml) 5.9 1.2 39.3 6.8
Tmax
(min) 6.0 0.0 5.6 1.1
AUC
(ug min/ml) 199 93,426 1735 1280,2351
TCE
Cmax
(ug/ml) <1.0 _ 15.9 1.1
Tmax
(min) ". « 10.6 3.7
AUC
(ug min/ml) 1.11* 0.5.2.46 241.5 196,298
'Obtained by extrapolation.
Table 10. Kim et al. 1990, Pharmacokinetic Data on














(ng/ml) 371 30 3814 1012 1084 145 3447 654
Tmax




164 8 166 23.4 114.2 14.9 175 22.7
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Table 11  Biood:saline and oil partition
coefficients Gargas et al. (1988)
Chemical Saline Std Error Olive Oil Std Error
CHCI3 3.38 0.09 402 12
TCE 0.83 0.30 553 46














CHCI3 20.8 0.1 21.1 1.5 13.9 1.9 203 5
TCE 21.9 1.4 27.2 3.4 10.1 2.7 554 21
CCI4 4.52 0.35 14.2 0.97 4.54 0.59 359 11
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FIG. 20.   HEPATOTOXICITY OF 1.0 ml CHCI3/kg
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BODY WEIGHT   OIL VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 38.77 <0.001
EXP 1 41.82
CHCI3 2 2487.77 111.23 <0.001
TCE 1 94.74 4.24 0.049
CHCI3 X TCE 2 45.18 2.02 0.151
ERROR 29 22.37













0.0             166.6          3.6            12
0.5             141.8          7.0           12
1.0             141.5          4.3            12
0.0               148.3          14.6          18
1.0              151.6          11.2         18
a 0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
BODY WE GHT    AQUEOUS VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 12.73 <0.001
EXP 1 1.58
CHCI3 2 1713.74               34.70 <0.001
TCE 1 52.16                 1.06 0.313



























0.0              153.0          14.0
1.0               149.7           10.7
18
18
ai.O ml CHCI3/kg is significantly lower than 0.5 ml CHCI3/kg (p<0.05),
0.5 ml CHCI3/kg is significantly lower than 0.0 ml CHCI3/kg (p<0.05) and
1.0 ml CHCI3/kg is significantly lower than 0.0 ml CHCI3/kg (p<0.05).
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RELATIVE LIVER WEIGHT   OIL VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 5.65 <0.001
EXP 1 0.280
CHCI3 2 0.401 8.03 0.002
TCE 1 0.152 3.04 0.092
CHCI3 X TCE 2 0.229 4.58 0.019
ERROR 29 0.050
RELATIVE LIVER WEIGHT    01 L VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b % of body wt DEVIATION N
0.0 0.0                     4.29 0.12 6
0.0 1.0                     4.48 0.19 6
0.5 0.0                     4.66 0.21 6
0.5 1.0                      4.38 0.38 6
1.0 0.0                      4.89 0.28 6
1.0 1.0                      4.60 0.18 6
3|n the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg (p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, there were no significant
differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.019)
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RELATIVE LIVER WEIGHT    AQUEOUS VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 7.15               <0.001
EXP 1                     0.966
CHCI3 2                    0.822 13.48              <0.001
TCE 1                     0.005 0.09                 0.766
CHCI3XTCE 2                   0.087 1.42                 0.258
ERROR 28                   0.061





























4.08             0.09
4.07              0.08
17
18
ai .0 ml CHCi3/kg is significantly lower than 0.0 and 0.5 ml CHCI3/kg
(p<0.05).   0.5 and 1.0 ml CHCI3/kg.are not significantly different.




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 17.88 <0.001
EXP 1 0.003
CHCI3 2 0.634 45.55 <0.001
TCE 1 0.020 1.41 0.244
CHCI3 X TCE 2 0.101 7.28 0.003
ERROR 29 0.014
RELATIVE KIDNEY WEIGHT    0 L VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE {ml/kg)b % of body wt DEVIATION N
0.0 0.0 0.74 0.03 6
0.0 1.0 0.80 0.03 6
0.5 0.0 1.25 0.19 6
0.5 1.0 0.96 0.10 6
1.0 0.0 1.18 0.19 6
1.0 1.0 1.21 0.15 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHC!3/kg (p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, 1.0 ml CHCI3/kg is significantly higher than 0.5 ml
CHCI3/kg (p<0.05), 0.5 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg (ie TCE alone) (p<0.05) and 1.0 ml CHCI3/kg is significantly
higher than 0.0 ml CHCI3/kg (ieTCE alone)(p<0.05).
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.005)
and 0.5 ml CHCI3/kg (p=0.012).
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RELATIVE KIDNEY WEIGHT    AQUEOUS VEHICLE^
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 6.06 <0.001
EXP 1 0.001
CHCI3 2 0.087 10.97 0.003
TCE 1 0.015 1.97 0.171
CHCI3 X TCE 2 0.049 6.22 0.006
ERROR 28 0.007
SBased on LOG(PCKID)
RELATIVE KIDNEY WEIGHT    AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (m /k9)a TCE (ml/kg)b % of body wt DEVIATION N
0.0 0.0 0.77 0.04 6
0.0 1.0 0.83 0.05 6
0.5 0.0 0.84 0.04 6
0.5 1.0 0.82 0.03 6
1.0 0.0 1.06 0.24 5
1.0 1.0 0.87 0.04 6
ain the absence of TCE, 1.0 ml CHCI3/kg is significantly higher than 0.0
and 0.5 ml CHCI3/kg(p<0.05). 0.0 and 0.5 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the CHCI3
levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.030).
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SERUM LDH    OIL VEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 14.18 <0.001
EXP 1 4.46
CHCI3 2 14.85                   16.93 <0.001
TCE 1 22.81                   26.01 <0.001
CHCI3 X TCE 2 8.83                   10.07 0.001
ERROR 29 0.78
asased on Log(LDH)
SERUM LDH    OIL VEHICLE
MEAN STANDARD
CHCI3 (m /k9)a TCE (ml/kg)b (lU/L) DEVIATION N
0.0 0.0 154.7 55.2 6
0.0 1.0 498.5 883.8 6
0.5 0.0 6958.3 5135.3 8
0.5 1.0 389.3 380.5 6
1.0 0.0 7387.7 8563.1 6
1.0 1.0 529.3 544.9 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, there were no significant
differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001)
and 1.0 ml CHCI3/kg (p=0.010).
SERUM LDH     AQUEOUS VEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 2.20 0.073
EXP 1 0.176
CHCI3 2 0.716 3.97 0.030
TCE 1 0.421 2.34 0.138
CHCI3 X TCE 2 0.314 1.75 0.193
ERROR 28 0.180
SBased on Log(LDH)



















41.6        12
53.1         12
312.2        11
0.0             231.0         258.1
1.0              156.7           49.8
17
18
ai.o ml CHCI3/kg is significantly higher than 0.0 ml CHCI3/kg (p<0.05).
No other differences were significant.
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SERUM AST    OILVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 40.23 <0.001
EXP 1 0.15
CHCI3 2 39.70 73.20 <0.001
TCE 1 28.92 53.33 <0.001
CHCI3 X TCE 2 11.21 20.68 <0.001
ERROR 29 0.54
aBased on Log{AST)
SERUM AST    OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (m!/kg)b (lU/L) DEVIATION N
0.0 0.0 60.2 6.7 6
0.0 1.0 74.2 42.4 6
0.5 0.0 8756.7 1967.4 6
0.5 1.0 367.5 487.9 6
1.0 0.0 5267.2 3847.5 6
1.0 1.0 980.3 841.1 6
3|n the absence of TCE, 1.0 ml CHCI3/kg is significantly
lower than 0.5 ml CHCI3/kg (p<0.05), 0.5 ml CHCI3/kg is significantly
higher than 0.0 ml CHCI3/kg (p<0.05) and 1.0 ml CHCI3/kg is significanlty
higher than 0.0 ml CHCI3/kg (p<0.05). In the presence of TCE, 1.0 ml
CHCI3/kg is significantly higher than 0.5 and 0.0 ml CHCI3/kg. 0.5 and 0.0
ml CHCI3/kg are not significantly different.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001)
and 1.0 ml CHCi3/kg (p=0.008).
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AST    AQUEOUS VEHICLE^
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 4.54 0.003
EXP 1 0.305
CHCI3 2 0.927 7.31 0.003
TCE 1 1.198 9.45 0.005
CHCI3 X TCE 2 0.240 1.89 0.170
ERROR 28 0.127
aBased on Log(AST)

























0.0              108.7





ai .0 ml CHC13/kg is significantly higher than 0.0 and 0.5 ml CHCI3/kg (p<0.05).
0.0 and 0.5 ml CHCi3/kg are not significantly different.
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SERUM 5' NlJCLEOTIDASE OIL VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 9.80 <0.001
EXP 1                        122710
CHCI3 2                          8352 2.80 0.077
TCE 1                          10127 3.40 0.076
CHCISxTCE 2                         12884 4.32 0.023
ERROR 29                           2980
SERUM5'NUC -EOTIDASE    0 L VEHICLE
STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b MEAN DEVIATION N
0.0 0.0 48.7 36.1 6
0.0 1.0 89.4 109.1 6
0.5 0.0 120.9 76.1 6
0.5 1.0 63.0 40.6 6
1.0 0.0 163.4 124.0 6
1.0 1.0 80.0 76.3 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 andl.O ml CHCI3/kg are not
significantly different. In the presence of TCE, there were no significant
differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.046)




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 7.15 <0.001
EXP 1 1.93
CHCI3 2 4.53 12.60 <0.001
TCE 1 2.01 5.60 0.025
CHCI3 X TCE 2 1.23 3.38 0.048
ERROR 29 0.36
asased on Log(CRE)
SERUM CREATININE    OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE {ml/kq)b (mg/dl) DEVIATION N
0.0 0.0 0.53 0.08 6
0.0 1.0 0.47 0.12 6
0.5 0.0 2.72 1.52 6
0.5 1.0 0.72 0.20 6
1.0 0.0 2.27 1.86 6
1.0 1.0 2.17 2.06 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, 1.0 ml CHCI3/kg is
significantly higher than 0.0 and 0.5 ml CHCI3/kg. 0.0 and 0.5 ml
CHCI3/kg are not significantly different.
^The TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.003).
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BLOOD UREA NITROGEN    OIL VEHICLES
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 14.37 <0.001
EXP 1 1.40
CHCI3 2 8.04 28.22 <0.001
TCE 1 2.71 9.50 0.005
CHCI3 X TCE 2 2.19 7.68 0.002
ERROR 29 0.29
asased on Log(BUN)
BLOOD UREA NITROGEN    OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (mg/dl) DEVIATION N
0.0 0.0                    20.8 2.4 6
0.0 1.0                    20.5 2.3 6
0.5 0.0                   169.5 80.5 6
0.5 1.0                    33.2 12.2 6
1.0 0.0                   141.0 101.7 6
1.0 1.0                   112.5 72.1 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, 1.0 ml CHCI3/kg is
significantly higher than 0.0 and 0.5 ml CHCI3/kg (p<0.05). 0.0 and 0.5 ml
CHCI3/kg are not significant.
3L00D UREA N TROGEN    AQUEOUS VEHICLES
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 3.67                   0.008
EXP 1 0.593
CHCi3 2 0.626 4.79                    0.016
TCE 1 0.693 5.30                    0.029
CHCI3 X TCE 2 0.368 2.82                    0.077
ERROR 28 0.131
asased on LOG(BUN)


































ai.O ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg (p<0.05). No other differences were significant.




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 24.80 <0.001
EXP 1 0.03
CHCI3 2 7.95 51.33 <0.001
TCE 1 3.79 24.44 <0.001
CHCI3 X TCE 2 1.67 10.75 <0.001
ERROR 29 0.15
SERUM ALT 24 HR   OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (lU/L) DEVIATION N
0.0 0.0 35.7                      7.6 6
0.0 1.0 45.0                    16.2 6
0.5 0.0 322.2                  157.5 6
0.5 1.0 105.2                    65.9 6
1.0 0.0 284.0                  175.4 6
1.0 1.0 94.5                     24.6 6
ain the absence of TCE, 0.5 andl.O ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg{p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, 0.5 andl .0 ml CHCI3/kg
are significantly higher than 0.0 ml CHCI3/kg. 0.5 and 1.0 ml CHCI3/kg
are not significantly different (p<0.05).
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.001)
and 1.0 ml CHCI3/kg (p=0.003).
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SERUM ALT 24 HR   AQUEOUS VEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 29 8.62 <0.001
EXP 1 0.60
CHCI3 2 2.45 13.89 <0.001
TCE 1 2.46 13.97 0.001
CHCI3 X TCE 2 0.86 4.86 0.017
ERROR 23 0.18
^Based on Log(ALT24)
SERUM ALT 24 HR   AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (lU/L) DEVIATION N
0.0 0.0 37.0 8.7 6
0.0 1.0 41.0 13.7 5
0.5 0.0 179.8 110.0 6
0.5 1.0 57.8 17.3 6
1.0 0.0 124.0 48.5 3
1.0 1.0 56.5 15.8 4
3|n the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg
are significantly higher than 0.0 ml CHCI3/kg. 0.5 and 1.0 ml CHCI3/kg
are not significantly different.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.019)
and 1.0 ml CHCI3/kg (p=0.052).




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 19.78 <0.001
EXP 1 2.80
CHCI3 2 39.15 34.86 <0.001
TCE 1 29.03 25.85 <0.001
CHCI3 X TCE 2 11.60 10.33 <0.001
ERROR 29 1.12
SERUM AL^r 48 HR   OIL VEHICLE
MEAN STANDARD
CHCi3 {mi/kg)a TCE (ml/kg)b (lU/L) DEVIATION N
0.0 0.0 35.8                       1.7 6
0.0 1.0 37.2                     11.4 6
0.5 0.0 6961.7                1853.8 6
0.5 1.0 271.0                  364.5 6
1.0 0.0 3802.7                3294.6 6
1.0 1.0 534.5                  621.0 6
3|n the absence of TCE, 1.0 ml CHCI3/kg is significantly lower than 0.5 ml
CHCI3/kg {p<0.05), 0.5 ml CHCI3/kg is significantly higher than 0.0 ml
CHCi3/kg (p<0.05) and 1.0 ml CHCI3/kg is significanlty higher than 0.0 ml
CHCi3/kg (p<0.05). In the presence of TCE, 0.5 and 1.0 ml CHCi3/kg are
significantly higher than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml
CHCI3/kg are not significantly different.
^The TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001).
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SERUM ALT 48 HR   AQUEOUS VEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 8.42 <0.001
EXP 1 0.22
CHCI3 2 0.56 7.25 0.003
TCE 1 2.29 29.52 <0.001
CHCI3 X TCE 2 0.36 4.57 0.019
ERROR 28 0.08
^Based on Log(ALT48)
SERUM ALT 4<3HR   AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (mi/kg)a TCE {ml/kg)b (lU/L) DEVIATION N
0.0 0.0                   36.5                      4.5 6
0.0 1.0                   30.2                      3.5 6
0.5 0.0                   46.3                    14.5 6
0.5 1.0                   28.3                      2.2 6
1.0 0.0                   94.6                    80.2 5
1.0 1.0                   32.3                      4.1 6
a In the absence of TCE, 1.0 ml CHCI3/kg is significantly higher than 0.5
and 0.0 ml CHCI3/kg(p<0.05). 0.0 and 0.5 ml CHCI3/kg are not
significantly different. In the presence of TCE, there were no significant
differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.5 ml CHC!3/kg (p=0.007)
and 1.0 ml CHCI3/kg (p=0.005).
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SERUM BILE ACIDS 24 HR   OIL VEHICLES
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 21 6.17 0.002
EXP 1 1.13
CHCI3 2 4.21 5.90 0.013
TCE i 8.83 12.38 0.003
CHCI3 X TCE 2 4.22 5.91 0.013
ERROR 15 0.71
^Based on Log(BAC24)
SERUM BILE ACIDS   24 HR   0 L VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (um/L) DEVIATION N
0.0 0.0                   24.8 20.7 4
0.0 1.0                   31.8 17.6 4
0.5 0.0                 296.3 263.2 4
0.5 1.0                   59.5 43.3 4
1.0 0.0                 223.0 166.6 4
1.0 1.0                    14.0 14.1 2
a In the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, there were no significant
differences in the CHCI3 levels.
t>The TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.038).
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SERUM BILES ACID 48 HR   OILVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 13.71 <0.001
EXP 1 1.60
CHCI3 2 23.90 25.23 <0.001
TCE 1 10.34 10.92 0.003
CHCI3 X TCE 2 7.32 7.73 0.002
ERROR 28 0.95
aSased on Log(BAC48)
SERUM BILE ACIDS   48 HR   0 L VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (um/L) DEVIATION N
0.0 0.0                   14.5 5.9 6
0.0 1.0                   27.6 7.3 5
0.5 0.0               1054.2 654.1 6
0.5 1.0                  132.0 157.5 6
1.0 0.0                 848.2 543.2 6
1.0 1.0                 122.3 92.5 6
a In the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, there were no significant
differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.018),
0.5 ml CHCI3/kg (p=0.041) and 1.0 ml CHCI3/kg (p=0.001).
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URINE AST 36 HR AQUEOUS VEHICLES
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 12.12 <0.001
EXP 1 0.54
CHCI3 2 7.86 13.73 <0.001
TCE 1 17.51 30.60 <0.001
CHCI3 X TCE 2 3.69 6.44 0.005
ERROR 28 0.57
asased on Log( NAST36)
URINE AST 36 HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 0.0 0.13 0.08 6
0.0 1.0 0.11 0.10 6
0.5 0.0 0.87 0.93 6
0.5 1.0 0.16 0.10 5
1.0 0.0 2.63 2.68 6
1.0 1.0 0.15 0.05 6
ain the absence of TCE, 1.0 ml CHCI3/kg is significantly higher than 0.5
ml CHCI3/kg (p<0.05), 0.5 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg (p<0.05) and 1.0 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg {p<0.05). In the presence of TCE, there were no significant
differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.021)
and 1.0 ml CHCI3/kg (p<0.001).




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 34.77 <0.001
EXP 1 <0.01
CHCI3 2 12.18 36.17 <0.001
TCE 1 25.74 74.45 <0.001
CHCI3 X TCE 2 10.08 29.92 <0.001
ERROR 29 0.34
URINE AS1r 36 HR OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 0.0 0.12                 0.07 6
0.0 1.0 0.16                 0.06 6
0.5 0.0 2.75                 0.06 6
0.5 1.0 0.16                  0.07 6
1.0 0.0 3.46                  1.87 6
1.0 1.0 0.29                 0.28 6
3|n the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg. 0.5 and 1.0 ml CHCI3/kg are not significantly
different (p<0.05).
In the presence of TCE, there were no significant differences in the
CHCI3 levels.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001)
and 1.0 ml CHCI3/kg {p<0.001).
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URINE AST 48 HR AQUEOUS VEHICLES
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 29 5.18 0.002
EXP 1 <0.01 -
CHCI3 2 5.48 6.14 0.007
TCE 1 5.90 6.60 0.017
CHCI3 X TCE 2 3.36 3.76 0.039
ERROR 23 0.89
asased on Log(NAST48)
URINE AST 48 HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (m /kg)a TCE {ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 0.0 0.16 0.10 6
0.0 1.0 0.14 0.05 5
0.5 0.0 0.89 0.80 6
0.5 1.0 0.59 0.62 3
1.0 0.0 2.95 3.77 6
1.0 1.0 0.20 0.17 4
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the CHCI3
levels.
bThe TCE levels are significantly different at 1.0 ml CHCI3/kg (p=0.033).
URINE AST 48 HR OILVEHICLEa
^Based on Log( NAST48)
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MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 32 24.12 <0.001
EXP 1 0.01
CHCI3 2 14.11 36.91 <0.001
TCE 1 14.66 38.35 <0.001
CHCI3 X TCE 2 4.83 12.62 <0.001
ERROR 26 0.38
URINE AS1r 48 HR OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 0.0 0.19                    0.07 6
0.0 1.0 0.27                    0.32 4
0.5 0.0 4.00                    1.22 6
0.5 1.0 0.33                    0.24 6
1.0 0.0 3.74                    1.85 5
1.0 1.0 0.92                    0.34 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, 1.0 ml CHCI3/kg is significantly higher than 0.0
and 0.5 ml CHCI3/kg(p<0.05). 0.0 and 0.5 ml CHCI3/kg are not
significantly different.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001)
and 1.0 ml CHCI3/kg (p=0.003).
140
URINE LDH 24 HR AQUEOUS VEHICLE^
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 33 15.67 <0.001
EXP 1 0.28
CHCI3 2 3.20 20.65 <0.001
TCE 1 2.39 15.44 <0.001
CHCI3 X TCE 2 2.34 15.12 <0.001
ERROR 27
^Based on Log(NLDH24)
URINE LDH 24 HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 {ml/kg)a TCE (ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 0.0                        0.31                  0.08 6
0.0 1.0                        0.49                 0.05 6
0.5 0.0                        2.41                  1.71 6
0.5 1.0                        0.58                 0.11 4
1.0 0.0                        1.41                  0.59 6
1.0 1.0                        0.60                 0.15 6
2|n the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the
CHCI3 levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.006),
0.5 ml CHCI3/kg (p=0.006) and 1.0 ml CHCI3/kg (p=0.006).
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URINE LDH  24 HR OILVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 28 7.93 <0.001
EXP 1 0.14
CHCI3 2 0.25 3.91 0.035
TCE 1 0.51 7.96 0.010
CHCI3 X TCE 2 0.34 5.37 0.013
ERROR 22 0.06
SBased on Log(NLDH24)
URINE LDH 24 HR OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 0.0                        0.42                 0.11 6
0.0 1.0                        0.45                 0.05 6
0.5 0.0                        1.02                 0.33 6
0.5 1.0                        0.42 1
1.0 0.0                        0.62                 0.17 6
1.0 1.0                        0.52                 0.12 4
3|n the absence of TCE, 1.0 ml CHCI3/kg is significantly lower than 0.5 ml
CHCI3/kg (p<0.05), 0.5 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg (p<0.05) and 1.0 ml CHCI3/kg is significanltly higher than 0.0 ml
CHCI3/kg (p<0.05).
In the presence of TCE, there were no significant differences in the CHCI3
levels.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.050).
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UR NELDH 36 H Ra
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 18.28 <0.001
EXP 1 8.03
TCE 1 14.96 52.28 <0.001
CHCI3 2 13.36 46.66 <0.001
VEHICLE 1 1.03 3.60 0.063
TCE X CHCI3 2 5.20 18.19 <0.001
TCE X VEH 1 0.29 1.00 0.322
VEH X CHCI3 2 0.56 1.95 0.151
TCE X CHCI3 X VEH 2 0.13 0.44 0.647
ERROR 59 0.29
aBased on Log{NLDH36)
URINE LDH 36 HR
MEAN STANDARD
CHCi3 (ml/kg)a TCE (ml/kg)t> (lU/IOmgCRE) DEVIATION N
0.0 6.0 0.31 0.13 12
0.0 1.0 0.34 0.12 12
0.5 0.0 2.45 1.89 12
0.5 1.0 0.56 0.21 12
1.0 0.0 3.98 3.72 12
1.0 1.0 0.58 0.26 12
ajn the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg{p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001)
and 1.0 ml CHCI3/kg (p<0.001).
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URINE LDH 48 HR AQUEOUS VEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 10.91 <0.001
EXP 1 0.44
CHCI3 2 4.48 10.28 <0.001
TCE 1 11.32 25.96 <0.001
CHCI3 X TCE 2 3.40 7.79 0.002
ERROR 28 0.44
asased on Log( NLDH48)
URINE LDH 48 HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 0.0 0.33 0.03 6
0.0 1.0 0.32 0.03 6
0.5 0.0 1.52 1.30 6
0.5 1.0 0.38 0.14 6
1.0 0.0 4.50 3.00 6
1.0 1.0 0.57 0.64 5
ain the absence of TCE, 1.0 ml CHCI3/kg is significantly higher than 0.5
ml CHCI3/kg (p<0.05), 0.5 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg (p<0.05) and 1.0 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg {p<0.05).
In the presence of TCE, there were no significant differences in the
CHCI3 levels (p<0.05).
^The TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.011)
and 1.0 ml CHCi3/kg (p=0.007).
^Based on Log( NLDH48)
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URINE LDH 48 HR OILVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 32.17 <0.001
EXP 1 0.20
CHCI3 2 17.50 61.51 <0.001
TCE 1 13.26 46.61 <0.001
CHCI3 X TCE 2 3.81 13.38 <0.001
ERROR 28 0.28
URINE LDH 48 HR OIL VEHICLE
MEAN STANDARD
CHCI3 {mi/kg)a TCE (ml/kg)t> (lU/IOmgCRE) DEVIATION N
0.0 0.0 0.29 0.10 6
0.0 1.0 0.30 0.12 6
0.5 0.0 6.36 2.14 6
0.5 1.0 0.81 0.39 6
1.0 0.0 6.24 3.33 5
1.0 1.0 1.34 0.81 6
3|n the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCi3/kg(p<0.05). 0.5 and 1.0 ml CHC13/kg are not
significantly different.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001)
and 1.0 ml CHCI3/kg (p=0.006).
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URINE ALT 36 HR a
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 58 4.28 <0.001
EXP 1 0.28
TCE 1 1.39 7.35 0.009
CHCI3 2 1.01 5.35 0.008
VEHICLE 1 2.46 13.02 0.001
TCEXCHCI3 2 1.36 7.18 0.002
TCE X VEH 1 0.36 1.90 0.175
VEH X CHCI3 2 0.19 0.99 0.379
TCE X CHCI3 X VEH 2 0.17 0.92 0.407
ERROR 46 0.19
aBased on LOG(NALT36)
URINE ALT 36 HR
MEAN STANDARD
CHCI3 (m /kg)a TCE (ml/kg)b (lU/IOmgCRE) DEVIATION N
0.0 6.0 0.12 0.04 11
0.0 1.0 0.15 0.06 9
0.5 0.0 0.22 0.09 10
0.5 1.0 0.14 0.06 10
1.0 0.0 0.35 0.29 10
1.0 1.0 0.17 0.14 9
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, there were no significant
differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.025)




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 3.28 0.002
EXP 1 0.89
TCE 1 2.10 5.20 0.027
CHCI3 2 2.46 6.10 0.005
VEHICLE 1 2.11 5.23 0.027
TCExCHCI3 2 1.15 2.85 0.068
TCE X VEH 1 0.33 0.83 0.367
VEH X CHCI3 2 0.28 0.69 0.509


















0.0         0.16             0.10          24
0.5        0,36            0.29         24
1.0        0.47            0.73          24
0.0          0.41                0.57        36
1.0         0.22              0.20       36
a 0.5 and 1.0 ml CHCI3/kg are significantly higher than 0.0 ml CHCI3/kg




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 5.46 <0.001
EXP 1 2.05
TCE 1 0.37 5.49 0.023
CHCI3 2 0.04 0.68 0.510
VEHICLE 1 0.57 8.42 0.005
TCE X CHCI3 2 0.37 5.50 0.007
TCE X VEH 1 0.14 2.05 0.157
VEH X CHCI3 2 0.20 2.94 0.060
TCE X CHCI3 X VEH 2 0.03 0.38 0.689
ERROR 59 0.07
aBasedonLog{NTPR12)
TOTAL PROTEIN  12 HR
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (mg/mg CRE) DEVIATION N
6.0 0.0 0.007 0.002 12
0.0 1.0 0.008 0.003 12
0.5 0.0 0.008 0.003 12
0.5 1.0 0.007 0.001 12
1.0 0.0 0.009 0.003 12
1.0 1.0 0.007 0.003 12
^In the absence of TCE, there were no significant differences in the
CHCI3 levels.
In the presence of TCE, 1.0 ml CHCI3/kg is significantly lower than 0.0 ml
CHCI3/kg (p<0.05). No other differences were significant.
bThe TCE levels are significantly different at 1.0 ml CHCI3/kg (p=0.006).
148
TOTAL PROTE N 24 HRS AQU EOUSVEHICL£3
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 3.27 0.014
EXP 1 0.26
CHCI3 2 1.46 6.66 0.004
TCE 1 0.03 0.16 0.694
CHCI3 X TCE 2 0.54 2.47 0.102
ERROR 29 0.22
asased on Log( NTPR24)


















0.009          0.002        12
0.005          0.002       12
0.008          0.002       12
0.0              0.008            0.003
1.0              0.007            0.002
18
18
ao.5 ml CHCI3/kg is significantly lower than 0.0 and 1.0 ml CHCI3/kg
(p<0.05). 0.0 and 1.0 ml CHCI3/kg are not significantly different.
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TOTAL PROTE N 36 HR AQUEOUS VEHICLEa
MEAN
SOURCE DP SQUARE F-VALUE P-VALUE
OVERALL 35 11.82 <0.001
EXP 1 0.03
CHCI3 2 0.25                 4.20 0.025
TCE 1 2.86               47.06 <0.001
CHCI3 X TCE 2 0.45                 7.45 0.002
ERROR 29 0.06
^Based on Log(NTPR36)
TOTAL PROTEIN 36 HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (mg/mg CRE) DEVIATION N
0.0 0.0 0.008 0.004 6
0.0 1.0 0.006 0.001 6
0.5 0.0 0.010 0.002 6
0.5 1.0 0.005 0.000 6
1.0 0.0 0.004 0.003 6
1            1.0 1.0 0.006 0.001 6           1
ain the absence of TCE, 1.0 ml CHCI3/kg is significantly different than 0.0
ml CHCI3/kg. No other differences were significant.
In the presence of TCE, there were no significant differences in the CHCI3
levels (p>0.05).
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p<0.001)
and 1.0 ml CHCI3/kg (p<0.001).
TOTAL PROTEIN   36 HR OIL VEHICLEa
^Based on Log(NTPR36 )
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MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 24.52 <0.001
EXP 1 1.03
CHCI3 2 0.31 5.52 0.009
TCE 1 2.71 48.38 <0.001
CHCI3 X TCE 2 1.94 34.68 <0.001
ERROR 29 0.06
TOTAL PROTEIN 36 HR OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (mg/mg CRE) DEVIATION N
0.0 0.0                       0.007               0.001 6
0.0 1.0                       0.010               0.002 6
0.5 0.0                       0.018               0.006 6
0.5 1.0                        0.007                0.002 6
1.0 0.0                        0.017                0.007 6
1.0 1.0                        0.006                0.003 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly higher
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p<0.001),
0.5 ml CHCI3/kg (p<0.001) and 1.0 ml CHCI3/kg (p<0.001).




SOURCE DP SQUARE F-VALUE P-VALUE
OVERALL 33 33.96 <0.001
EXP 1 0.06
CHCI3 2 0.85 19.01 <0.001
TCE 1 3.48 78.01 <0.001
CHCI3 X TCE 2 2.03 45.54 <0.001
ERROR 27 0.04
TOTAL PROTEIN 48 HR OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (mg/mg CRE) DEVIATION N
0.0 0.0                       0.007               0.000 6
0.0 1.0                       0.009               0.002 6
0.5 0.0                       0.026               0.005 6
0.5 1.0                        0.007                0.001 6
1.0 0.0                       0.019               0.005 5
1.0 1.0                       0.008               0.002 5
3|n the absence of TCE, 1.0 ml CHCI3/kg is significantly lower than 0.5 ml
CHCI3/kg (p<0.05), 0.5 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg (p<0.05) and 1.0 ml CHCI3/kg is significantly higher than 0.0 ml
CHCI3/kg (p<0.05).
In the presence of TCE, there were no significant differences in the CHCI3
levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.002),
0.5 ml CHCI3/kg (p<0.001) and 1.0 ml CHCI3/kg (p=0.003).
-'fi^'PgB*^?^?^
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TOTAL PROTE N 48 HR AQUEOUS VEHICLE^
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 3.11 0.018
EXP 1 0.16
CHCI3 2 0.44 2.87 0.073
TCE 1 0.55 3.60 0.068
CHCI3 X TCE 2 0.58 3.80 0.035
ERROR 28 0.15
asased on Log(NTPR48)
TOTAL PROTEIN 48 HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE {ml/kg)b (mg/mg CRE) DEVIATION N
0.0 0.0 0.008 0.002 6
0.0 1.0 0.008 0.001 6
0.5 0.0 0.008 0.004 6
0.5 1.0 0.008 0.003 6
1.0 0.0 0.019 0.015 6
1.0 1.0 0.008 0.003 5
ain the absence of TCE, 1.0 ml CHCI3/kg is significantly different than 0.0
and 0.5 ml CHCI3/kg(p<0.05). 0.0 and 0.5 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the CHCI3
levels.




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 2.94 0.003
EXP 1 4140
TCE 1 3226 7.70 0.007
CHCI3 2 2033 4.85 0.011
VEHICLE 1 1241 2.96 0.091
TCE X CHCI3 2 486 1.16 0.321
TCE X VEH 1 70 0.17 0.684
VEH X CHCI3 2 508 1.21 0.305
TCE X CHCI3 X VEH 2 15 0.04 0.964
ERROR 59 419













0.0        74.2            21.5         24
0.5        55.8            18.4         24
1.0        63.7            27.4         24
0.0          57.9            24.0          36
1.0         71.3            21.4         36
a 0.5 ml CHCI3/kg is significantly lower than 0.0 ml CHCI3/kg (p<0.05).
No other differences were significant.
•
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URINE CREATININE 12 HR AQUEOUS VEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 10.47 <0.001
EXP 1 GET
CHCI3 2 0.84 12.74 <0.001
TCE 1 0.10 1.46 0.237
CHCI3 X TCE 2 1.17 17.68 <0.001
ERROR 29 0.07
aBasedonLog(CRE12)
URINE CREATININE 12HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 {ml/kg)a TCE (ml/kg)b (mg/dl) DEVIATION N
0.0                       0.0 115.8                    9.2 6
0.0                       1.0 54.4                   17.5 6
0.5                       0.0 45.1                   15.0 6
0.5                        1.0 67.7                  21.3 6
1.0                       0.0 45.1                      6.7 6
1.0                        1.0 48.9                     6.4 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the CHCI3
levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg p<0.001).
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URINE CREATININE  12 HR OILVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 2.46 0.048
EXP 1 0.12
CHCI3 2 1.66 6.97 0.003
TCE 1 <0.01 0.01 0.908
CHCI3xTCE 2 0.03 0.14 0.869
ERROR 29 0.24
aBasedonLog{CRE12)



























79.6            36.7
86.0            42.4
18
18
ao.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
URINE CREATININE 24 HR
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 6.14 <0.001
EXP 1 111
TCE 1 1106 2.53 0.117
CHCI3 2 13660 ' 31.20 <0.001
VEHICLE 1 250 0.57 0.453
TCE X CHCI3 2 1118 2.55 0.086
TCExVEH 1 81 0.19 0.669
VEH X CHCI3 2 203 0.46 0.631
TCE X CHCI3 X VEH 2 363 0.83 0.441
ERROR 59 438

































a 0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
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URINE CREATININE 36 HR
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 9.73 <0.001
EXP 1 10658
TCE 1 806 1.31 0.256
CHCI3 2 13592 22.03 <0.001
VEHICLE 1 21736 35.39 <0.001
TCExCHCI3 2 1381 2.25 0.114
TCExVEH 1 5083 8.28 0.056
VEHXCHCI3 2 1609 2.62 0.081
TCE X CHCI3 X VEH 2 205 0.34 0.717
ERROR 59 614

































3 0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg (p<0.05).
0.5 and 1.0 ml CHCI3/kg are not significantly different.
URINE CREATININE 48 HR
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 69 4.46 <0.001
EXP 1 3353
TCE 1 1342 1.85 0.179
CHCI3 2 7396 10.17 <0.001
VEHICLE 1 14057 19.33 <0.001
TCE X CHCI3 2 497 0.68 0.509
TCE X VEH 1 1 0.00 0.964
VEH X CHCI3 2 1258 1.73 0.186





















23.0         24
28.0 24
41.1 22
0.0         73.7





a 0.5 and 1.0 ml CHCI3/kg are significantly different than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
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UREA NITROGEN 6 HR
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE     1
OVERALL 71 2.37 0.014
EXP 1 115.58
TCE 1 55.06 1.22 0.274
CHCI3 2 179.58 3.98 0.024
VEHICLE 1 210.72 4.67 0.035
TCE X CHCI3 2 96.42 2.14 0.127
TCE X VEH 1 170.84 3.78 0.057
VEH X CHCI3 2 45.05 1.00 0.375
TCE X CHCI3 X VEH 2 45.01 1.00 0.375
ERROR 59 45.14



































ai.O ml CHCI3/kg is significantly higher than 0.0 ml CHCI3/kg (p<0.05).
No other differences were significant.
UREA NITROGEN 12 HR AQU EOUSVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 8.66 <0.001
EXP 1
CHCI3 2                     0.57 15.94 <0.001
TCE 1                      0.29 8.14 0.008
CHCI3 X TCE 2                      0.11 2.95 0.069
ERROR 28                      0.04
aBasedonLog(NUN12)



































ai .0 ml CHCI3/kg is.significantly higher than 0.0 and 0.5 ml CHCI3/kg
(p<0.05). 0.0 and 0.5 ml CHCI3/kg are not significantly different.
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UREA NITROGEN  12HR OILVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 7.76 <0.001
EXP 1 <0.01
CHCI3 2 0.24 11.59 <0.001
TCE 1 0.36 17.23 <0.001
CHCI3 X TCE 2 0.06 3.08 0.061
ERROR 29 0.02
aBasedonLog(NUN12)



































a 0.5 and 1.0 ml CHCI3/kg are significantly higher than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
UREA NITROGEN 24 HR AQUEOUS VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 5.43 0.001
EXP 1 262.91
CHCI3 2 303.85 10.65 <0.001
TCE 1 41.45 1.46 0.236
CHCI3 X TCE 2 8.45 0.30 0.746
ERROR 29 28.52



































ao.5 ml CHCI3/kg is significantly lower than 0.0 and 1.0 ml CHCI3/kg
(p<0.05). 0.0 and 1.0 ml CHCI3/kg are not significantly different..
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UREA NITROGEN 24 HR OIL VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 5.54 0.001
EXP 1 337.86
CHCI3 2 98.92 5.45 0.010
TCE 1 22.09 1.22 0.279
CHCI3 X TCE 2 23.12 1.27 0.295
ERROR 29





























29.8              7.0
28.2              4.1
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ai .0 ml CHCI3/kg is significantly higher than 0.0 and 0.5 ml CHCI3/kg
(p<0.05). 0.0 and 0.5 ml CHCI3/kg are not significantly different.
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UREA NITROGEN 36 HR AQUEOUS VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35                                                 8.18 <0.001
EXP 1                      214.98
CHCI3 2                      122.51                7.86 ~     0.002
TCE 1                       28.44                1.83 0.187
CHCI3 X TCE 2                      138.05               8.86 0.001
ERROR 29                       15.58
UREA NITROGEN 36 HR AQUEOUS VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (mg/mg UCRE) DEVIATION N
0.0 0.0 25.33                   5.70 6
0.0 1.0 28.08                   3.13 6
0.5 0.0 28.97                   3.82 6
0.5 1.0 30.50                   3.54 6
1.0 0.0 37.87                  5.42 6
1.0 1.0 28.29                  5.88 6
3|n the absence of TCE, 1.0 ml CHCI3/kg is significantly higher than 0.0
and 0.5 ml CHCi3/kg{p<0.05). 0.0 and 0.5 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the CHCI3
levels.
bThe TCE levels are significantly different at 1.0 ml CHCI3/kg (p=0.007).
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UREA NITROGEN 36 HR OIL VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 7.12 <0.001
EXP 1 102.99
CHCI3 2 399.59 14.62 <0.001
TCE 1 76.94 2.82 0.104
CHCI3 X TCE 2 93.83 3.44 0.046
ERROR 29 27.31
UREA NITROGEN 36 HR OIL VEHICLE
MEAN STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b (mg/mg UCRE) DEVIATION N
0.0 0.0 22.2 3.3 6
0.0 1.0 25.5 2.3 6
0.5 0.0 25.9 2.6 6
0.5 1.0 34.2 4.6 6
1.0 0.0 36.8 11.4 6
1.0 1.0 34.0 3.0 6
3 In the absence of TCE, 1.0 ml/kg CHCI3 is significantly higher than 0.0
and 0.5 ml/kg CHCI3.(p<0.05). 0.5 and 0.0 are not significantly different.
In the presence of TCE, 0.5 and 1.0 ml/kg CHCI3 are significantly higher
than 0.0 ml/kg CHCI3.(p<0.05). 0.5 and 1.0 mi/kg CHCI3 are not
significantly different.
bCHCI3 and TCE interact significantly at 0.5 ml/kg CHCI3 (p=0.003).
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PH 6HR AQUEOUS VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 6.60 <0.001
EXP 1 <0.01
CHCI3 2 1.27 4.59 0.019
TCE 1 6.19 22.32 <0.001
CHCI3 X TCE 2 1.21 4.36 0.022
ERROR 29 0.28
•
pH 6HR AQUEOUS VEHICLE
STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b MEAN DEVIATION N
0.0 0.0 8.34                  0.34 6
0.0 1.0 6.78                  0.63 6
0.5 0.0 7.25                 0.41 6
0.5 1.0 6.82                  0.47 6
1.0 0.0 7.21                   0.49 6
1.0 1.0 6.71                  0.68 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the CHCI3 levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.001).
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pH 6HR   OILVEH CLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 5.44 <0.001
EXP 1 GET
CHCI3 2 4.44 15.15 <0.001
TCE 1 0.21 0.70 0.409
CHCI3 X TCE 2 0.24 0.82 0.452
ERROR 29 0.29
•





















0.0              7.26





a 0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
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pH 24 HR OILVEHCLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 9.55 <0.001
EXP 1 0.001
CHCI3 2 0.064 22.48 <0.001
TCE 1 0.004 1.24 0.274
CHCI3 X TCE 2 0.016 5.51 0.009
ERROR 29
aBased on LOG(pH24)
pH 24 HR OILVEH CLE
STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b MEAN DEVIATION N
0.0 0.0                          7.16                   0.47 6
0.0 1.0                         6.79                  0.33 6
0.5 0.0                         5.97                  0.22 6
0.5 1.0                         6.55                  0.28 6
1.0 0.0                        6.01                  0.32 6
1.0 1.0                        6.12                 0.39 6
Sjn the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, 1.0 ml CHCI3/kg is significantly lower than 0.0
and 0.5 ml CHCI3/kg (p<0.05). 0.0 and 0.5 ml CHCI3/kg are not
significantly different.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.004).
asased on LOG(pH24)
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pH24HR   AQUEOUS VEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 24.32 <0.001
EXP 1 0.025
CHCI3 2 0.160 55.62 <0.001
TCE 1 0.002 0.67 0.421
CHCI3 X TCE 2 0.037 12.70 <0.001
ERROR 29 0.003
pH24HR   AQUEOUS VEHICLE
•
STANDARD
CHCI3 (m /k9)a TCE (ml/kg)b MEAN DEVIATION N
0.0 0.0 8.36 0.18 6
0.0 1.0 7.33 0.86 6
0.5 0.0 6.37 0.31 6
0.5 1.0 6.46 0.20 6
1.0 0.0 6.12 0.09 6
1.0 1.0 6.62 0.34 6
ain the absence of TCE, 1.0 ml CHCI3/kg is significantly lower than 0.5 ml
CHCI3/kg (p<0.05), 0.5 ml CHCI3/kg is significantly lower than 0.0 ml
CHCI3/kg (p<0.05) and 1.0 ml CHCI3/kg is significantly lower than 0.0 ml
CHCI3/kg (p<0.05).
In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.008)
and 1.0 ml CHCI3/kg (p=0.003).
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pH  36 HPa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 21.39 <0.001
EXP 1 2.22
TCE 1 0.01 0.14 0.705
CHCI3 2 6.62 100.28 <0.001
VEHICLE 1 0.60 9.08 0.004
TCE X CHCI3 2 0.26 3.87 0.026
TCE X VEH 1 0.09 1.37 0.247
VEHxCHCI3 2 0.03 0.48 0.624





CHCI3 {ml/kg)a TCE (ml/kg)b MEAN DEVIATION N
0.0 6.0 6.99 0.2§ 12
0.0 1.0 6.76 0.52 12
0.5 0.0 5.96 0.17 12
0.5 1.0 6.50 0.23 12
1.0 0.0 5.89 0.20 12
1.0 1.0 6.07 0.41 12
S|n the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCi3/kg{p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg
are significantly lower than 0.0 ml CHCI3/kg. 0.5 and 1.0 ml CHCI3/kg are
not significantly different,




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 69 19.97 <0.001
EXP 1 0.43
TCE 1 1.01 4.82 0.032
CHCI3 2 16.96 81.37 <0.001
VEHICLE 1 1.88 9.05 0.004
TCEXCHCI3 2 1.87 8.98 <0.001
TCE X VEH 1 0.09 0.47 0.495
VEH X CHCI3 2 3.21 15.42 <0.001





CHCI3 (ml/kg)a TCE ml/kg)b MEAN DEVIATION N
0.0 6.0 8.31 0.18 12
0.0 1.0 7.89 0.65 12
0.5 0.0 6.47 0.61 12
0.5 1.0 7.03 0.75 12
1.0 0.0 6.23 0.38 11
1.0 1.0 6.86 0.79 11
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different. In the presence of TCE, 0.5 and 1.0 ml CHCI3/kg
are significantly lower than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml
CHCI3/kg are not significantly different.
bThe TCE levels are significantly different at 0.5 ml CHCI3/kg (p=0.036)
and 1.0 ml CHCI3/kg (p=0.032).
'^WW*"
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VOLUME 6 HP OILVEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 35 5.66 <0.001
EXP 1 10.13
CHCI3 2 5.50 7.79 0.002
TCE 1 1.56 2.21 0.148
CHCI3 X TCE 2 0.65 0.92 0.411
ERROR 29 0.71



















0.82          12
1.15          12
1.03          12
0.0              3.00





a 0.5 and 1.0 ml CHCI3/kg are significantly higher than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
VOLUME 12 HRa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 1.92 0.050
EXP 1 0.011 0.859
TCE 1 0.065 0.18 0.670
CHCI3 2 2.610 7.33 0.001
VEHICLE 1 0.331 0.93 0.339
TCEXCHCI3 2 0.588 1.65 0.200
TCExVEH 1 0.004 0.01 0.914
VEH X CHCI3 2 0.157 0.44 0.645




































ao.5 and 1.0 ml CHCI3/kg are significantly higher than 0.0 ml CHCI3/kg




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 2.77 0.005
EXP 1 1.254
TCE 1 0.087 0.26 0.615
CHCI3 2 3.47 10.23 <0.001
VEHICLE 1 0.116 0.34 0.560
TCE X CHCI3 2 0.099 0.29 0.748
TCE X VEH 1 0.276 0.81 0.371
VEH X CHCI3 2 0.262 0.77 0.466




































30.5 and 1.0 ml CHCI3/kg are significantly higher than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
VOLUME 48 HR AQUEOL S VEHICLE
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 4.30 0.003
EXP 1 0.25
CHCI3 2 35.01 8.83 0.001
TCE 1 7.11 1.79 0.191
CHCi3 X TCE 2 12.47 3.14 0.058
ERROR 28 3.97



















1.79         11
2.60         12
1.83         12
0.0             5.55





a 0.5 ml CHCI3/kg is significantly higher than 0.0 and 1.0 ml CHCI3/kg
(p<0.05). 0.0 and 1.0 ml CHCI3/kg are not significantly different.
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OSMOLALITY 12 HR AQUEOUS VEHICLE
STANDARD
CHCI3 (ml/kg)a TCE (ml/kg)b MEAN DEVIATION N
0.0 0.0 1873 163 6
0.0 1.0 1167 461 6
0.5 0.0 893 268 6
0.5 1.0 1262 418 6
1.0 0.0 1081 224 6
1.0 1.0 1318 220 6
ain the absence of TCE, 0.5 and 1.0 ml CHCI3/kg are significantly lower
than 0.0 ml CHCI3/kg(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not
significantly different.
In the presence of TCE, there were no significant differences in the CHCI3
levels.
bThe TCE levels are significantly different at 0.0 ml CHCI3/kg (p=0.007)




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 7.84 <0.001
EXP 1 479383
TCE 1 160083 1.07 0.304
CHCI3 2 6049454 40.58 <0.001
VEHICLE 1 170236 1.14 0.290
TCE X CHCI3 2 127456 0.86 0.431
TCE X VEH 1 23148 0.16 0.695
VEH X CHCI3 2 128934 0.86 0.426

















366          24
398          24









a 0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg




SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 71 8.32 <0.001
EXP 1 1669878
TCE 1 32555 0.25 0.616
CHCI3 2 3147160 24.53 <0.001
VEHICLE 1 3574692 27.87 <0.001
TCE X CHCI3 2 292976 2.28 0.111
TCE X VEH 1 66 0.00 0.982
VEH X CHCI3 2 270051 2.11 0.131































a 0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 mi CHCi3/kg are not significantly different.
OSMOLALITY 48 HR AQUEOUS VEHICLES
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 34 3.04 0.020
EXP 1 0.60
CHCi3 2 0.50 4.64 0.018
TCE 1 0.01 0.05 0.819
CHCI3 X TCE 2 0.16 1.45 0.252
ERROR 29 get
^Based on Log( OSM048)





























^0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
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OSMOLALITY 48 HR OILVEHICLEa
MEAN
SOURCE DF SQUARE F-VALUE P-VALUE
OVERALL 32 7.75 <0.001
EXP 1 0.13
CHCi3 2 3.06 18.74 <0.001
TCE 1 0.54 3.28 0.082
CHCI3 X TCE 2 0.52 3.21 0.057
ERROR 26 0.16
aSased on Log(OSM048)















547           12
473           11
209           10
0.0              1008         713
1.0              1171         590
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a 0.5 and 1.0 ml CHCi3/kg are significantly lower than 0.0 ml CHCI3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
a 0.5 and 1.0 ml CHCI3/kg are significantly lower than 0.0 ml CHC!3/kg
(p<0.05). 0.5 and 1.0 ml CHCI3/kg are not significantly different.
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Oil vs Aqueous Comparison of ALT and BAG levels caused bv CHCI3 do.gage.g








1                       40.407

















a 1.0 ml CHCI3/kg in oil is significantly greater than 1.0 ml CHCI3/kg in
aqeous vehicle (p<0.05).




OVERALL                    18
VEHICLE                       1
ERROR                        17
2.098
0.369
5.69              0.029





OIL                                     284





a 1.0 ml CHCI3/kg in oil is significantly greater than 1.0 ml CHCI3/kg in
aqeous vehicle (p=0.03).
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21                       -                          22.72
1                       30.839               22.72









148                                      49
52                                        26.7
6
5
a 1.0 ml CHCI3/kg in oil is significantly greater than 1.0 ml CHCI3/kg in
aqeous vehicle (p<0.001).




OVERALL                    23
VEHICLE                       1
ERROR                        22
30.839
2.481
26.32            <0.001





OIL                                  6962
AQUEOUS                          46
1692                               6
13                               6
a 0.5 ml CHCI3/kg in oil is significantly greater than 0.5 ml CHCI3/kg in
aqeous vehicle (p<0.05).
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1                       34.65

















a 0.5 ml CHCI3/kg in oil is significantly greater than 0.5 ml CHCI3/kg in
aqeous vehicle (p<0.05).












4.84               0.047
4.84               0.047
asased on LOG[BAG)







228                            4
18                            4
a 0.5ml CHCI3/kg in oil is significantly greater than 0.5 ml CHGI3/kg in
aqeous vehicle {p<0.05).
